610 Medizin und Gesundheit
Refine
Has Fulltext
- yes (733)
Year of publication
- 2021 (733) (remove)
Document Type
- Journal article (519)
- Doctoral Thesis (209)
- Other (3)
- Preprint (2)
Keywords
- COVID-19 (18)
- inflammation (16)
- SARS-CoV-2 (10)
- immunohistochemistry (8)
- MRI (7)
- biomarker (7)
- breast cancer (7)
- ischemic stroke (7)
- neuroinflammation (7)
- prostate cancer (7)
- Aspergillus (6)
- Parkinson's disease (6)
- adrenocortical carcinoma (6)
- depression (6)
- oxidative stress (6)
- 3D-Druck (5)
- CXCR4 (5)
- T cells (5)
- cartilage (5)
- cytokines (5)
- echocardiography (5)
- macrophages (5)
- multiple myeloma (5)
- multiple sclerosis (5)
- obesity (5)
- stroke (5)
- survey (5)
- therapeutic drug monitoring (5)
- tissue engineering (5)
- ADHD (4)
- Bordetella pertussis (4)
- DNA damage (4)
- Multiples Myelom (4)
- Parkinson-Krankheit (4)
- Tissue Engineering (4)
- additive manufacturing (4)
- atherosclerosis (4)
- attention-deficit/hyperactivity disorder (ADHD) (4)
- children (4)
- deep learning (4)
- imaging (4)
- machine learning (4)
- magnetic resonance imaging (4)
- mice (4)
- mouse model (4)
- neural networks (4)
- paraganglioma (4)
- pheochromocytoma (4)
- toxicity (4)
- 3D printing (3)
- B cells (3)
- Biomarker (3)
- Diabetes mellitus (3)
- FGFR (3)
- Glaukom (3)
- Kernspintomografie (3)
- Osteoarthritis (3)
- Palliativmedizin (3)
- Pankreaskarzinom (3)
- Periphere arterielle Verschlusskrankheit (3)
- Plasmozytom (3)
- Propriozeption (3)
- Prostatakrebs (3)
- Roux-en-Y gastric bypass surgery (3)
- Schlaganfall (3)
- Strahlentherapie (3)
- Validierung (3)
- Vitamin D (3)
- acute heart failure (3)
- antimicrobial resistance (3)
- antimicrobial stewardship (3)
- biokinetics (3)
- biomarkers (3)
- blood–brain barrier (3)
- cancer (3)
- cerebrospinal fluid (3)
- dosimetry (3)
- drug repurposing (3)
- ecological momentary assessment (3)
- endovascular (3)
- extracellular matrix (3)
- forensic neuropathology (3)
- hypofractionation (3)
- immunomodulation (3)
- immunotherapy (3)
- inflammatory bowel disease (3)
- interview (3)
- mechanotransduction (3)
- medicine (3)
- melanoma (3)
- melt electrowriting (3)
- metabolism (3)
- mouse (3)
- mouse models (3)
- myocardial infarction (3)
- neurodegeneration (3)
- neutrophils (3)
- oligodendrocytes (3)
- physical activity (3)
- positron emission tomography (3)
- psoriasis (3)
- psychological distress (3)
- recurrence (3)
- surgery (3)
- systematic review (3)
- therapy (3)
- thrombosis (3)
- total knee arthroplasty (3)
- translation (3)
- Angststörung (2)
- Aortenaneurysma (2)
- Autoantikörper (2)
- BDNF (2)
- Blut-Hirn-Schranke (2)
- Bridging (2)
- Brustkrebs (2)
- CD28 (2)
- CSF (2)
- CT angiography (2)
- Candida albicans (2)
- Chemotherapieresistenz (2)
- Cochlear-Implantat (2)
- Coronavirus (2)
- DNA repair (2)
- Depression (2)
- EAE (2)
- Endoprothese (2)
- Entwicklung (2)
- Entzündung (2)
- Epigenetik (2)
- Erratum (2)
- Fragebogen (2)
- Gelenkknorpel (2)
- GvHD (2)
- HFpEF (2)
- HIV (2)
- HIV-Infektion (2)
- Halcyon (2)
- Haut (2)
- Hernie (2)
- Hernienchirurgie (2)
- Herzinfarkt (2)
- Herzinsuffizienz (2)
- Hospiz (2)
- Hypophosphatasia (2)
- Hüftgelenk (2)
- Induzierte pluripotente Stammzelle (2)
- Inflammation (2)
- Injury Severity Score (2)
- Intensivkapazitäten (2)
- Interleukin (2)
- KEAP1 (2)
- Kniegelenk (2)
- Knorpel (2)
- Körperwahrnehmung (2)
- L929 (2)
- LC/MS (2)
- Laborleistungstests (2)
- Lagerungsplagiozephalus (2)
- MAP-Kinase (2)
- MPFL (2)
- MSC (2)
- MSCs (2)
- MYC (2)
- Makrophage (2)
- Maus (2)
- Mausmodell (2)
- Medizinische Ausbildung (2)
- Methylierung (2)
- Minisequenzierung (2)
- Monoklonaler Antikörper (2)
- Monoklonaler bispezifischer Antikörper (2)
- Mundschleimhaut (2)
- NET (2)
- NFAT (2)
- NK cells (2)
- Natürliche Killerzelle (2)
- Neisseria gonorrhoeae (2)
- Neisseria meningitidis (2)
- PD-1 (2)
- PET (2)
- Palliativversorgung (2)
- Pandemie (2)
- Parkinson’s disease (2)
- Patientenzufriedenheit (2)
- Polytrauma (2)
- Präparation (2)
- Puppenhandillusion (2)
- Pyrosequenzierung (2)
- Pädiatrie (2)
- RNA (2)
- Raman-Spektroskopie (2)
- Regulatorischer T-Lymphozyt (2)
- Resistenz (2)
- Risikofaktoren (2)
- SARS‐CoV‐2 (2)
- Sprachentwicklung (2)
- Stroke (2)
- Substantia nigra (2)
- THA (2)
- Tansania (2)
- Therapie (2)
- Therapieerfolg (2)
- Toll-like-Rezeptoren (2)
- Tourette syndrome (2)
- Ultraschall (2)
- Ultraschalldiagnostik (2)
- Ventilation (2)
- Viszeralchirurgie (2)
- Vitamin-D-Mangel (2)
- Wilms' tumor (2)
- Wurzelkanalbehandlung (2)
- Zellkultur (2)
- Zelltod (2)
- active zone (2)
- acute myeloid leukemia (2)
- acute respiratory distress syndrome (2)
- adaptive immunity (2)
- adipose-derived stromal cells (2)
- adjuvant treatment (2)
- adolescence (2)
- adrenal (2)
- adrenal gland (2)
- aging (2)
- alloreactive T cells (2)
- aneurysm (2)
- animal models (2)
- anorexia nervosa (2)
- antidepressants (2)
- antigen testing (2)
- anxiety (2)
- apoptosis (2)
- arrhythmia (2)
- autoimmune disease (2)
- biocompatibility (2)
- biomedicine, general (2)
- bleeding (2)
- bone mineral density (2)
- bronchopulmonary dysplasia (2)
- caloric restriction (2)
- cancers and neoplasms (2)
- cardiac magnetic resonance (2)
- cardiomyopathy (2)
- cardiovascular genetics (2)
- cartilage regeneration (2)
- case report (2)
- catecholamines (2)
- ceramides (2)
- cerebellar tDCS (2)
- childhood (2)
- chronic heart failure (2)
- chronotype (2)
- cochlear implantation (2)
- comet assay (2)
- complementary alternative medicine (2)
- critical care (2)
- deep brain stimulation (2)
- dental trauma (2)
- depressive symptoms (2)
- dermatology (2)
- desmosome (2)
- desmosomes (2)
- diabetic neuropathy (2)
- diagnosis (2)
- diagnostic markers (2)
- diagnostics (2)
- diastolic dysfunction (2)
- dilated cardiomyopathy (2)
- direct-acting antivirals (2)
- drug discovery (2)
- electroactive (2)
- electrohydrodynamic (2)
- electrophysiology (2)
- electrospinning (2)
- embodiment (2)
- endothelium (2)
- environmental health (2)
- epidemiology (2)
- epigenetics (2)
- evolution (2)
- exercise (2)
- exosomes (2)
- experimental autoimmune encephalomyelitis (2)
- extracellular vesicles (2)
- fatigue (2)
- fibrin (2)
- forensic neurotraumatology (2)
- gait (2)
- glycoprotein VI (2)
- health-related quality of life (2)
- heart failure (2)
- hip (2)
- hippocampus (2)
- hyaluronic acid (2)
- hypercortisolism (2)
- hypophosphatasia (2)
- hypoxia (2)
- image-guided radiation therapy (2)
- immunoassay (2)
- immunosenescence (2)
- impedance spectroscopy (2)
- infection (2)
- inhibition (2)
- intestinal epithelial barrier (2)
- intraoperative imaging (2)
- iron (2)
- isothermal titration calorimetry (2)
- kidney (2)
- kinematic alignment (2)
- laboratory proficiency testing (2)
- large vessel occlusion (2)
- lenalidomide (2)
- liraglutide (2)
- long-term outcome (2)
- lymphocytes (2)
- mHealth (2)
- mRNA (2)
- magnesium phosphate cement (2)
- major depression (2)
- malignant tumors (2)
- mass spectrometry (2)
- mechanical thrombectomy (2)
- medical education (2)
- megakaryocytes (2)
- meningioma (2)
- meta-analysis (2)
- methionine restriction (2)
- microglia (2)
- migrants (2)
- minisequencing (2)
- molecular imaging (2)
- molecular medicine (2)
- mortality (2)
- mucoepidermoid carcinoma (2)
- multisensory integration (2)
- neural stem cells (2)
- neuroblastoma (2)
- neurogenesis (2)
- neuropathy (2)
- neuroprotection (2)
- neurosurgery (2)
- neurotrophins (2)
- next generation sequencing (2)
- occupational medicine/industrial medicine (2)
- optimization (2)
- optogenetics (2)
- orale Antikoagulation (2)
- osteoarthritis (2)
- osteoporosis (2)
- outcome (2)
- p53 (2)
- pain (2)
- pandemic (2)
- pediatric (2)
- pemphigus (2)
- pharmacogenetics (2)
- pharmacology/toxicology (2)
- phosphorylation (2)
- platelets (2)
- pleomorphic adenoma (2)
- polycaprolactone (2)
- polymer processing (2)
- postoperative Blutung (2)
- postoperative nausea and vomiting (2)
- prediction (2)
- prefrontal cortex (2)
- preterm infants (2)
- primary care (2)
- proteins (2)
- psychology (2)
- pulmonary hypertension (2)
- pyrosequencing (2)
- renal artery (2)
- retrospektiv (2)
- risk factors (2)
- rotation (2)
- salivary gland tumors (2)
- scaffold (2)
- scientific guidelines (2)
- secondary prevention (2)
- segmentation (2)
- single-sided deafness (2)
- skin biopsy (2)
- smoking (2)
- specificity (2)
- sphingolipids (2)
- stress (2)
- super-resolution microscopy (2)
- tMCAO (2)
- targeted therapy (2)
- telemedicine (2)
- theranostics (2)
- thrombo-inflammation (2)
- tight junction (2)
- timing (2)
- tinnitus (2)
- total joint arthroplasty (2)
- total knee replacement (2)
- transcription (2)
- treatment (2)
- tumor microenvironment (2)
- type 2 diabetes (2)
- validation (2)
- viability (2)
- viral infection (2)
- wall shear stress (2)
- 1,2-benzisothiazolinone (1)
- 13C-Methacetin-Atemtest (1)
- 177Lu SPECT/CT imaging (1)
- 177Lu-OPS201 (1)
- 19. Jahrhundert (1)
- 1950er (1)
- 1p36 deletion syndrome (1)
- 22q11.2 deletion syndrome (1)
- 3 D rotational fluoroscopy (1)
- 3D Druck (1)
- 3D cell cultures (1)
- 3D fluoroscopy (1)
- 3D microfiber (1)
- 3D powder printing (1)
- 3D tumor model (1)
- 3D-Biodruck (1)
- 3D-Druckzähne (1)
- 3D-Gewebemodell (1)
- 3D-Kultur (1)
- 3D-Modell (1)
- 3D-Stereophotogrammetrie (1)
- 3D-gedruckter Zahn (1)
- 3D-printed tooth (1)
- 3R (1)
- 3d printing (1)
- 4-1BB Agonist (1)
- 4-1BB agonist (1)
- 4D flow MRI (1)
- 5-HTTLPR (1)
- 53BP1 (1)
- 68Ga-OPS202 (1)
- 7 T (1)
- 7-Dehydrocholesterol (1)
- 7T (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- A53T mutation (1)
- A53T-Mutation (1)
- A549 (1)
- ABC-Transporter (1)
- ACC (1)
- ACM (1)
- ACTH (1)
- ADGRL3 (1)
- ADHS (1)
- AHF (1)
- ALI culture (1)
- ALS (1)
- ALS treatment (1)
- ALT (1)
- AML (1)
- APOBEC3G (1)
- ARIA (1)
- ARVC (1)
- ASC (1)
- ASCs (1)
- ATF5 (1)
- ATMP (1)
- ATRX (1)
- ATTRv amyloidosis (1)
- AUY-922 (1)
- AZD4547 (1)
- Ab interno trabeculectomy (1)
- Acoustic radiation force imaging (ARFI) (1)
- Adenokarzinom (1)
- Adenylate cyclase toxin (1)
- Adhärenz (1)
- Adhäsivbrücke (1)
- Adipose (1)
- Adipose-Derived Stromal/Stem Cells (1)
- Adipositas (1)
- Adoleszenz (1)
- Adrenokortikales Karzinom (1)
- Advanced Glycation Endproducts (1)
- Advanced glycosylation end products (1)
- Africa (1)
- Aiolos (1)
- Airlift-Kultur (1)
- Akt (1)
- Akute Leukämie (1)
- Alginate-Gelatine (1)
- Allergiediagnostik (1)
- Allogene Stammzelltransplantation (1)
- Alopecia areata (1)
- Alternaria (1)
- Altersdepression (1)
- Altersmedizin (1)
- Alterspsychiatrie (1)
- Alzheimer's disease (1)
- Alzheimerkrankheit (1)
- Alzheimer’s disease (1)
- Amantadine (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Anaphylaxie (1)
- Angiogenese (1)
- Angiographie (1)
- Angst (1)
- Angstintensität (1)
- Angstsensitivität (1)
- Angstverhalten (1)
- Antibiotikafreisetzung (1)
- Antibiotikum (1)
- Antibody (1)
- Antidepressiva (1)
- Antiepileptika (1)
- Antigen CD137 (1)
- Antigen CD40 (1)
- Antikonvulsiva (1)
- Antikörper-Fusionsproteine (1)
- Antipsychotics (1)
- Antipsychotika (1)
- Anämie (1)
- Anästhetika-induzierte Postkonditionierung (1)
- Aortenklappenersatz (1)
- Aortenringassay (1)
- Apis mellifera (1)
- Appendizitis (1)
- ArcCHECK (1)
- Arrhythmie (1)
- Arteriosklerose (1)
- Arthrose (1)
- Arzt ohne Gewissen – Privat-Klinik Prof. Lund (1959) (1)
- Arztfilme (1)
- Aspergillose (1)
- Atresie (1)
- Audiologie (1)
- Audiology (1)
- Aufmerksamkeitsdefizit-Syndrom (1)
- Aureobasidium (1)
- AurisID (1)
- Autophagie (1)
- B (1)
- B cell deficiency (1)
- B-Zell-Lymphom (1)
- B-cell (1)
- BB/OKL rats (1)
- BCG (1)
- BCOR (1)
- BCORL1 (1)
- BM (1)
- BMP-6 (1)
- BON-1 (1)
- BRAF (1)
- BRD (1)
- BRENDA (1)
- BSS directive (1)
- Bahnung (1)
- Basketball (1)
- Bauchspeicheldrüsenkrebs (1)
- Begrenzung (1)
- Begrenzung am Lebensende (1)
- Beris, Johannes (1)
- Berufssport (1)
- Bestrahlung (1)
- Bestrahlung von Hirnmetastasen (1)
- Bestrahlungsplan (1)
- Big Five (1)
- Biodruck (1)
- Biofabrikation (1)
- Biofilm (1)
- Biologika (1)
- Biomarker der Fibrose (1)
- Biomaterial (1)
- Biomechanik (1)
- Bioreactor (1)
- Biotinte (1)
- Blepharoplastik (1)
- Blinddarmentzündung (1)
- Blood contamination (1)
- Bluthochdruck (1)
- Blutkontamination (1)
- Bluttransfusion (1)
- Blutverlust (1)
- Bombus terrestris (1)
- Bone Mineral Density (1)
- Bouldern (1)
- Braune Fettzelle (1)
- Bruchpilot (1)
- Bruton's tyrosine kinase inhibitor CC-292 (1)
- Bruxismus (1)
- Brücke (1)
- Business Process Models (1)
- C-terminal domain (1)
- CA2+ channels (1)
- CA3 pyrimidal cells (1)
- CAD/CAM (1)
- CAR T (1)
- CAR T-cell (1)
- CAR-T-cell (1)
- CARAT (1)
- CCR7 (1)
- CD28-SA (1)
- CD30 (1)
- CD319 (1)
- CD4+ T-cells (1)
- CD40 agonist (1)
- CD56 (1)
- CD8 (1)
- CD8-Lymphoyzten (1)
- CD96 (1)
- CDH13 (1)
- CDK4 Inhibitor (1)
- CDK4 inhibitor (1)
- CDL (1)
- CI-1040 (1)
- CIP2A (1)
- CLRN2 (1)
- CMR (1)
- CMV (1)
- CMV-specific cellular immunity (1)
- CNS diseases (1)
- COH29 (1)
- COPD (1)
- COVID‐19 (1)
- CRC (1)
- CRISPR-Cas Systems (1)
- CRISPR-Cas9 (1)
- CRISPR/Cas-Methode (1)
- CRISPR/Cas9 (1)
- CS1 (1)
- CT (1)
- CT perfusion (1)
- CT-angiography (1)
- CTLA-4 (1)
- CTNNB1 (1)
- CXCL12 (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- CXCR7 (1)
- CYP11B enzymes (1)
- CYP2C9 (1)
- CYP3A4 (1)
- CaCo-II-Zellen (1)
- CaMKII (1)
- Ca\(^{2+}\) signalling (1)
- Caco2 cells (1)
- Cadherin (1)
- Cadherin-13 (CDH13) (1)
- Cadherine (1)
- Caenorhabditis elegans (1)
- Calcium-Aufnahme (1)
- Calciumphosphat (1)
- Candida auris (1)
- Capecitabin (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cardiomyocyte (1)
- Cardioperfusion (1)
- Cas9 (1)
- Caspr (1)
- Cavity quantum electrodynamics (1)
- Celecoxib (1)
- Cell death and comet assay (1)
- Cell-Assisted Lipotransfer (1)
- Cerebrolysin (1)
- Checkpoint-Inhibitor (1)
- Chemokin CXCL10 (1)
- Chemokine (1)
- Chemokinrezeptor (1)
- Chemosensititvität (1)
- Children (1)
- Chirurgie (1)
- Cholesterin (1)
- Cholesterol (1)
- Cholesterol metabolism (1)
- Chondrozyten-Subpopulationen (1)
- Chronisch thromboembolische pulmonale Hypertonie (1)
- Chronische HBV-Infektion (1)
- Ciliary neurotrophic factor (1)
- Citalopram (1)
- Claudicatio intermittens (1)
- Claudin2 (1)
- Clinical Neuroradiology (1)
- Co-culture system (1)
- Collective effects in quantum optics (1)
- Colombia (1)
- Complement system (1)
- Compliance (1)
- Compliance <Patient> (1)
- Computertomographie Angiographie (1)
- Computertomography Angiography (1)
- Connexin (1)
- Corona virus (1)
- Crespi effect (1)
- Crohn's disease (1)
- Crohn’s Disease (1)
- Cryptorchidism (1)
- Cushing-Syndrom (1)
- Cushing’s disease (1)
- Cushing’s syndrome (1)
- Cutaneous metastatic Crohn’s disease (1)
- Cx43 (1)
- CysLTR1 (1)
- Cysteine‐Rich Domain (CRD) (1)
- Cystic fibrosis liver disease (CFLD) (1)
- Cystische Fibrose (1)
- Cytokeratine (1)
- DBT (1)
- DDS (1)
- DDS-Test (1)
- DHCR7 (1)
- DNA methylation (1)
- DNA-Methylierung (1)
- DNA-PK (1)
- DNAM-1 (1)
- DOACs (1)
- DOTA-EB-TATE (1)
- DSC2 (1)
- DSG2 (1)
- DUB inhibitor (1)
- Data Warehouse (1)
- Deep learning (1)
- DeepSqueak (1)
- Delta-Valve (1)
- Dendritische Zelle (1)
- Dentalkeramik (1)
- Dentin sealing (1)
- Dentinversiegelung (1)
- Depressivität (1)
- Desipramin (1)
- Desmosom (1)
- Diabetes Mellitus (1)
- Diabetes mellitus Typ 2 (1)
- Diabetische Neuropathie (1)
- Diagnostik (1)
- Differenzierung (1)
- Digitale Subtraktionsangiographie (1)
- Diphenylcyclopropenon (1)
- Direct Drive Simulation (1)
- Dominant intraprostatic lesion (1)
- Dominante intraprostatische Läsion (1)
- Dopaminergic PAM cluster neurons (1)
- Dosisanalyse (1)
- Drosophila (1)
- Dsg2 (1)
- Dsg3-Depletion (1)
- Dsg3-depletion (1)
- Dual-Source Computertomography (1)
- Dual-Source-Computertomographie (1)
- Duloxetin (1)
- Duodenalatresie (1)
- E-Zigaretten (1)
- E/e’ (1)
- EBER in situ hybridization (1)
- ECAP (1)
- ECG-gated PET (1)
- ECM coating (1)
- ECMO (1)
- EEG (1)
- EEG frequency band analysis (1)
- EEG preprocessing (1)
- EEG processing (1)
- EGF (1)
- EGFR (1)
- EMT (1)
- EPMS (1)
- ERBB receptors (1)
- ERK (1)
- ESCAlife (1)
- ESPED (1)
- EVT (1)
- EZH1 (1)
- EZH2 (1)
- Early-Life Stress (1)
- Echinococcus multilocularis (1)
- Eingangsuntersuchung (1)
- Eisenhomöostase (1)
- Eisenoxid-Nanopartikel (1)
- Elastomere Schmerzpumpe (1)
- Elektroimpedanztomographie (1)
- Elektrophysiologie (1)
- Elektrostimulation (1)
- Embolisation (1)
- Emotional behavior (1)
- Endodontie (1)
- Entscheidungsfindung (1)
- Enzyme‐Linked Immunosorbent Assay (1)
- Epistaxis (1)
- Epithel (1)
- Epstein-Barr virus (1)
- Ergebnisreproduzierbarkeit (1)
- Ertaubung (1)
- Escherichia coli (1)
- Escitalopram (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- Exposition (1)
- Expositionslernen (1)
- Extrakorporale Membranoxygenation (1)
- Extrapyramidales System (1)
- Extrazelluläre Matrix (1)
- Extrazellulärvesikel (1)
- Eye Movement Modeling Examples (1)
- FAP (1)
- FAPI PET/CT (1)
- FARS1 (1)
- FBXW7 (1)
- FDG (1)
- FDG PET/CT (1)
- FGF (1)
- FGF-pathway (1)
- FGF/FGFR signalling (1)
- FGFR signaling (1)
- FGFR1 (1)
- FINCA (1)
- Fabry-Krankheit (1)
- Fatigue (1)
- Fatty Triangle (1)
- Federal Republic of Germany (1)
- Ferroptose (1)
- Ferroptosis (1)
- Fersenbeinbruch (1)
- Fettsucht (1)
- Fibromyalgia (1)
- Fibromyalgie (1)
- Fibrose (1)
- Filtrierende Trabekulotomie (FTO) (1)
- Filtrierender Trabekulotomie (1)
- Flavonoide (1)
- Fn14 (1)
- Formative Prüfung (1)
- Fractalkin (1)
- Fragebogenvalidierung (1)
- Frailty (1)
- Fraktur (1)
- Frucht ohne Liebe (1955/56) (1)
- Frühdiagnostik (1)
- Fuchsbandwurm (1)
- Fundusautofluoreszenz (1)
- Fungiplex Candida Auris (1)
- Funktionelle Kernspintomografie (1)
- Funktionsdiagnostik (1)
- Furchtkonditionierung (1)
- Fusarium (1)
- GABA-A receptor (1)
- GABA\(_{A}\) receptor (1)
- GABAergic neurons (1)
- GCA (1)
- GDNF (1)
- GDNF5 (1)
- GIST (1)
- GMP (1)
- Galactomannanantigen (1)
- Gallium-68 Pentixafor (1)
- Gebrechlichkeit (1)
- Gefäßverschluss (1)
- GelAGE (1)
- Gelenkendoprothese (1)
- Gelenkinfektion (1)
- Gen BRCA 1 (1)
- Gen BRCA 2 (1)
- Genanalyse (1)
- Generalisierte Angststörung (1)
- Genetics (1)
- Genome Editing (1)
- Genotoxicity (1)
- Genotoxizität (1)
- Geriatrie (1)
- German Hepatitis C-Registry (1)
- Germany (1)
- Gerontopsychiatrie (1)
- Geskinnte Muskelfasern (1)
- Glaukomoperation (1)
- Glioblastom (1)
- Gliom (1)
- Glucose Starvation (1)
- Glucosephosphatdehydrogenase (1)
- Glucosestoffwechsel (1)
- Glukoseaufnahme (1)
- Glycinrezeptor (1)
- Glykomodifizierung (1)
- Glykosylierung (1)
- Grad-seq (1)
- Grave’s disease (1)
- Grundfrequenzkontur (1)
- Gruppendiskussion (1)
- H3K27me3 (1)
- HA modifiedCNF membranes (1)
- HAART (1)
- HCV cure (1)
- HEV (1)
- HFQ (1)
- HHV-6 (1)
- HIV-1 (1)
- HIV-infection (1)
- HMGB1 (1)
- HNSC (1)
- HPP (1)
- HRQL (1)
- HRUS (1)
- HSP90-Inhibition (1)
- Hals-Nasen-Ohrheilkunde (1)
- Hautbiopsie (1)
- Head and neck cancers (1)
- Head orthosis therapy (1)
- Heart development (1)
- Heart failure (1)
- Helicobacter pylori (1)
- Helicobacter pylori eradication (1)
- Helicobacter-pylori-Eradikation (1)
- Hepatischer Ischämie-Reperfusionsschaden (1)
- Hepatitis B (1)
- Hepatitis B Virus (1)
- Hepatitis E (1)
- Hepatozelluläres Karzinom (1)
- Herpesvirus (1)
- Herzchirurgie (1)
- Herzmuskelkrankheit (1)
- High risk prostate cancer (1)
- Hippo pathway (1)
- Hippocampus (1)
- Hirnmetastase (1)
- Hirnmetastasen (1)
- Histone gamma H2AX (1)
- Hitzeschock-Proteine (1)
- Hochrisiko Prostatakarzinom (1)
- Hodgkin lymphoma (1)
- Hornhaut (1)
- Horowitz Quotient (1)
- Huh6 (1)
- Human Transcriptome (1)
- Humanalbumin (1)
- Humane Tumorzelllinien (1)
- Hyaliner Knorpel (1)
- Hydatide (1)
- Hydrocephalus (1)
- Hydrogel (1)
- Hydroxybutyrat <3-> (1)
- Hydroxyethylstärke (1)
- Hyperkapnie (1)
- Hypertonie (1)
- Hypoadrenalismus (1)
- Hypoglykämie (1)
- Hyponatriämie (1)
- Hypophosphatasie (1)
- Hypoxia (1)
- Hämangiom (1)
- Hämodialyse (1)
- Hüfte (1)
- Hüftendoprothetik (1)
- Hüftgelenkprothese (1)
- Hüftgelenksersatz (1)
- ICD-10 (1)
- ICD-CRT (1)
- ICM (1)
- ICU capacities (1)
- ICU treatment (1)
- IDO (1)
- IDSA (1)
- IFN-γ ELISpot (1)
- IGRT (1)
- IKZF1 (1)
- IKZF3 (1)
- IL-10 (1)
- IL-1β (1)
- IL-6 (1)
- ILEX (1)
- IP3-Signaling (1)
- IPOS (1)
- IRF4 (1)
- IcaR (1)
- Idiopathisches Parkinson-Syndrom (1)
- IgG (1)
- Ikaros (1)
- Immunaktivierung (1)
- Immunantwort (1)
- Immunological synapse (1)
- Immunreaktion (1)
- Impedanztomografie (1)
- Impfung (1)
- Impulsivität (1)
- In vitro (1)
- IncuCyte\(^®\)S3 (1)
- Index lesion (1)
- Indexläsion (1)
- Indolamin-2,3-Dioxygenase (1)
- Indoleamine-2,3-dioxygenase (1)
- Indoor Bouldering (1)
- Induced Pluripotent Stem Cells (1)
- Informationsweitergabe (1)
- Inhibitor (1)
- Insulin (1)
- Integrated Palliative care outcome scale (1)
- IntelliCage (1)
- Interaktionen (1)
- Interleukin 1-beta (1)
- Interleukin 12 (1)
- Interleukin-4 Antagonist (1)
- International Conference on Tumor Microenvironment (4 : 2007 : Florenz) (1)
- Invasive Aspergillose (1)
- Invasive Pilzinfektionen (1)
- Inzisionalhernie (1)
- Iridektomie (1)
- Ischemia (1)
- Isokinetik (1)
- JUN (1)
- Juvenile Psychose (1)
- KIT (1)
- Kalkaneusfraktur (1)
- Kandidatengen (1)
- Kaposi sarcoma (1)
- Karotis-Intima-Media-Dicke (1)
- Keratine (1)
- Keratinozyt (1)
- Keratinozyten (1)
- Kernspintomographie (1)
- Ketogene Diät (1)
- Ketogene Kost (1)
- Keuchhusten (1)
- Ki67 (1)
- Kieferorthopädie (1)
- Kindesalter (1)
- Klassische Zuggurtung (1)
- Kleinkern (1)
- Klonale T-Zellen (1)
- Knochenzement (1)
- Knochenzemente (1)
- Knockout <Molekulargenetik> (1)
- Knorpelimplantate (1)
- Knorpelintegration (1)
- Kognitive Beeinträchtigung (1)
- Kohlenstoff-13-Exhalationstest (1)
- Kollagensynthese (1)
- Kolonkarzinom (1)
- Kommunikationstraining (1)
- Komorbiditäten bei CTEPH (1)
- Komorbiditäten bei PAH (1)
- Komplement (1)
- Komplikation (1)
- Komplikationsrate (1)
- Konfokale Ramanspektroskopie (1)
- Konstruktvalidität (1)
- Kontraktion (1)
- Konventionelle Trabekulektomie (TE) (1)
- Konventionellen Trabekulektomie (1)
- Kopforthesentherapie (1)
- Kraft (1)
- Kraftverhalten Oberschenkelmuskulatur (1)
- Krüppel-like factor (1)
- Körperliche Aktivität (1)
- Körpertherapie (1)
- Künstliche Ernährung (1)
- L-arginine (1)
- LC3-assoziierte Phagozytose (1)
- LDH-assay (1)
- LDL cholesterol (1)
- LEOSS (1)
- LESA (1)
- LINGO-1 (1)
- LMI1195 (1)
- LMNA (1)
- LRIG1 (1)
- LV dilatation (1)
- LVNC (1)
- LVO (1)
- Lactatdehydrogenase (1)
- Langerhans cells (1)
- Lao PDR (1)
- Lasiocarpin (1)
- Lebendzellmikroskopie (1)
- Lebensqualität nach stroke (1)
- Leberfibrose (1)
- Leberfunktion (1)
- Leberversagen (1)
- Leberzellkrebs (1)
- Leberzirrhose (1)
- Lehrforschung (1)
- Leistenhernie (1)
- Leistungsdiagnostik (1)
- Leitlinie (1)
- Lenalidomid (1)
- Lernen (1)
- Letalität (1)
- Lewy-Pathologie (1)
- Lewy-like pathology (1)
- Lichtheimia (1)
- Life expectancy (1)
- Linkes Vorhofohr (1)
- Lippen-Kiefer-Gaumenspalte (1)
- Lithium-Disilikat-verstärkte Keramik (1)
- Locus coeruleus (1)
- Lokale Feldpotentialaktivität (1)
- Long COVID (1)
- Luminespib (1)
- Lunge (1)
- Lungenfunktion (1)
- Lymphom (1)
- Lysosomale Speicherkrankheit (1)
- MAINZPouch (1)
- MALT-Lymphom (1)
- MALT-Lymphoma (1)
- MASK (1)
- MAX (1)
- MDR (1)
- MEK-Inhibition (1)
- MEK5/ERK5 (1)
- MGMT (1)
- MHC I (1)
- MHC II (1)
- MIBG scintigraphy (1)
- MITF-low (1)
- MPFL-Ersatz (1)
- MPFL-Plastik (1)
- MS (1)
- MS-18 (1)
- MSIS (1)
- MYCN (1)
- Macrophage Migration Inhibitory Factor (MIF) (1)
- Macrophages (1)
- Magenlymphom (1)
- Magnet-Partikel-Spektroskopie (1)
- Maldescensus testis (1)
- Massage (1)
- Massagetherapie (1)
- Massive parallele Sequenzierung (1)
- Matlab (1)
- Mbt (1)
- Mechanical deformation (1)
- Mechanorezeptor (1)
- Mechanotransduktion (1)
- Medication-related osteonecrosis of the jaw (1)
- Medikamenten-assoziierte Kiefernekrose (1)
- Medizingeschichte (1)
- Medizinisches Aufklärungsgespräch (1)
- Megakaryopoese (1)
- Melanom (1)
- Melkersson-Rosenthal-Syndrom (1)
- Melodielänge (1)
- Meningoenzephalitis (1)
- Menstruationszyklus (1)
- Merkel cell carcinoma (1)
- Mesenchymal stromal cells (1)
- Mesenchymale Stammzellen (1)
- Mesenchymzelle (1)
- Micronucleus (1)
- Mikrosomale Leberfunktion (1)
- Mineral Trioxid Aggregat (1)
- Mini-Open (1)
- Mitochondrium (1)
- Mitofusin2 (1)
- Mitotane (1)
- Mittelohrimplantat (1)
- Modifizierung (1)
- Molecular neuroscience (1)
- Monozyt (1)
- Morbus Fabry (1)
- Morbus Parkinson (1)
- Mouse Model (1)
- Mukosamodell (1)
- Multiple myeloma (1)
- Multisensorische Integration (1)
- Mundgesundheitsbezogene Lebensqualität (1)
- Mundschleimhautzellen (1)
- Muscle (1)
- Muskel (1)
- Muskelfasern (1)
- Muskelkraft (1)
- Muskelkraft bei Vorhofflimmern (1)
- Muster (1)
- Mutagenität (1)
- Myb-MuvB complex (1)
- Mykobakterien (1)
- Mykobakteriose (1)
- Myocardial infarction (1)
- Myocardial-perfusion SPECT (1)
- Myokardinfarkt (1)
- Myokarditis (1)
- Myokardprotektion (1)
- NA (1)
- NBA Combine (1)
- NBAS (1)
- NEC (1)
- NF-2 (1)
- NFE2L2 (1)
- NFκB (1)
- NHLRC2 (1)
- NIHSS (1)
- NIR-Spektroskopie (1)
- NK cell deficiency (1)
- NOAC (1)
- NOP10 (1)
- NR3C1 (1)
- NRF2 (1)
- NSCLC (1)
- NSG animals (1)
- NVP-AUY922 (1)
- Nachbehandlung (1)
- Nachkriegsfilm (1)
- Nachkriegszeit (1)
- Nachruf (1)
- Nachsorge (1)
- Narbenhernie (1)
- Narkose (1)
- Nasenbluten (1)
- Nasenschleimhaut (1)
- Nasenschleimhautzellen (1)
- Natrium-23 (1)
- Navigation (1)
- Nebennierenrindencarcinom (1)
- Nebennierenrindeninsuffizienz (1)
- Negative geotaxis (1)
- Neovaskularisationsglaukom (1)
- Nervenbiopsie (1)
- Nervenblockade (1)
- Nervenultraschall (1)
- Neugeborenenhörscreening (1)
- Neurofascin (1)
- Neurogeriatrie (1)
- Neuroscience (1)
- Neutrophil granulocyte (1)
- Neutrophiler Granulozyt (1)
- New Wundartzney (1)
- Nicotinamid-N-Methyltransferase (1)
- Nierenarterie (1)
- Non-Hodgkin-Lymphom (1)
- Nrf2 (1)
- Nucleus subthalamicus (1)
- Nährstoffmangel (1)
- O(6)-Methylguanine-DNA Methyltransferase (1)
- OHIP-G14 (1)
- OHRQoL (1)
- Oberarzt Dr. Solm (1954/55) (1)
- Offenwinkelglaukom (1)
- Ohrgeräusch (1)
- Okulodentodigitale Dysplasie (1)
- Olea (1)
- One Health (1)
- Operation (1)
- Operationstechnik (1)
- Optikusnervenscheidendurchmesser (1)
- Oralmukosa (1)
- Oralmukosamodell (1)
- Organoids (1)
- Orofaziale Granulomatose (1)
- Orofazialer Bereich (1)
- Orofazialer Schmerz (1)
- Osteoporose (1)
- Overdrainage (1)
- Oxidative Stress (1)
- Oxidativer Stress (1)
- PAK4 (1)
- PCR diagnostics (1)
- PD-L1 (1)
- PD184352 (1)
- PDE2 (1)
- PET/CT (1)
- PI-3-kinase (1)
- PIA/ica (1)
- PLAG1 rearrangement (1)
- PMDD (1)
- PMR (1)
- PMS (1)
- PPGL (1)
- PROM (1)
- PSMA (1)
- PTA (1)
- PTCL (1)
- PTEN (1)
- PU.1 (1)
- PWV (1)
- PYY3-36 (1)
- PaDaWaN (1)
- Paclitaxel (1)
- Pain drawing (1)
- Palbociclib (1)
- Palliative Care (1)
- Palliativoperation (1)
- Paprosky (1)
- Parkinson (1)
- Patella (1)
- Patellaluxation (1)
- Patellofemorale Instabilität (1)
- Pathophysiologie (1)
- Pathophysiologische Mechanismen (1)
- Patientencompliance (1)
- Patientenschulungen (1)
- PcdhgC3 (1)
- Pedobarographie (1)
- Pemphigus (1)
- Pericardium (1)
- Perikard (1)
- Perikardiozentese (1)
- Perikardpunktion (1)
- Peripheral Artery Disease (1)
- Permeabilität (1)
- Phagozytose (1)
- Physikalische Therapie (1)
- Physiotherapie (1)
- Plattenepithelcarcinom (1)
- Plattenosteosynthese (1)
- Polkörper (1)
- Polyneuropathie (1)
- Polyphenol (1)
- Portlandzement (1)
- Positronen-Emissions-Tomografie (1)
- Postischämischer Reperfusionsschaden (1)
- Postkardiotomie (1)
- Postoperativer Schmerz (1)
- Postoperatives Vorhofflimmern (1)
- Posturale Stabilität (1)
- Prednisolon (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Primary hyperparathyroidism (pHPT) (1)
- Primary radiation therapy (1)
- Primäre Bestrahlung (1)
- Primärelement (1)
- Primäres Offenwinkelglaukom (1)
- Primärresistenz (1)
- Primärzellen (1)
- Process Model Comprehension (1)
- Prognose (1)
- Prognoseschätzung (1)
- Prognosescore (1)
- Prognosescores (1)
- Prognostik (1)
- Propranolol (1)
- Propranolol-Therapie (1)
- Propylenglykol (1)
- Proteinmodifizierung (1)
- Protocadherine (1)
- Präeklampsie (1)
- Prämenstruelle Dysphorische Störung (1)
- Prämenstruelles Syndrom (1)
- Prämenstruum (1)
- Präparationslehre (1)
- Prävention (1)
- Präzisionsmedizin (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pulmonal arterielle Hypertonie (1)
- Pulmonale Hypertonie (1)
- Pulsatile (1)
- Punktion (1)
- Punktmutation (1)
- Purpureocillium (1)
- Pyrrolizidinalkaloide (1)
- QAF (1)
- QGP-1 (1)
- QT-Verlängerung (1)
- QT-prolongation (1)
- Qualitätsindikator (1)
- Quantitative Fundusautofluoreszenz (1)
- Quantitative Sonoelastographie (1)
- Quantum optics with artificial atoms (1)
- RET6 (1)
- RHO (1)
- RIM-binding protein (1)
- RNA Expression (1)
- RNA polymerase II (1)
- RNA probe (1)
- RNA splicing (1)
- RNA structure (1)
- RNA virus (1)
- RNA-binding proteins (1)
- RNA-sequencing (1)
- RNAScope (1)
- RNR (1)
- RNS-Interferenz (1)
- ROC-Kurve (1)
- ROCK (1)
- RRID: AB_2315425 (1)
- RRID: AB_2337244 (1)
- RRM2 (1)
- RT-PCR (1)
- RT-qPCR (1)
- Radiation sensitivity (1)
- Radioonkologie (1)
- Radiosensibilisierung (1)
- Radiosensitivität (1)
- Ranvier-Schnürring (1)
- Ratte (1)
- Raucher (1)
- Real time quantitative PCR (1)
- Regenerative Medicine (1)
- Regenerative Medizin (1)
- Registerdaten (1)
- Regulatorische T-Lymphozyt (1)
- Rektumkarzinom (1)
- Reruptur (1)
- Resilienz (1)
- Restaurationsqualität (1)
- Resveratrol (1)
- Retina (1)
- Retinale Bildgebung (1)
- Revaskularisierung (1)
- Reverse Schulterendoprothese (1)
- Reverse Transkriptase-Polymerase-Kettenreaktion (1)
- Rezeptorblocker (1)
- Rezidiv (1)
- Rheumatoide Arthritis (1)
- Robotik (1)
- Rotatorenmanschette (1)
- Rotatorenmanschettenruptur (1)
- Rotavirus (1)
- Ruxolitinib (1)
- Röntgen-Thorax (1)
- S-glutathionylation (1)
- SARS-CoV (1)
- SARS-CoV- 2 (1)
- SCC (1)
- SCN5a (1)
- SEMA3A (1)
- SIRS (1)
- SLAMF7 (1)
- SLC6A4 (1)
- SMN (1)
- SNB19 (1)
- SNRI (1)
- SOAT (1)
- SOAT Inhibitoren (1)
- SOFA Score (1)
- SPRED (1)
- SPRED2 (1)
- SR/Mitochondriales Feedback (1)
- SSRI (1)
- Salinomycin (1)
- Sars-CoV-2 (1)
- Scaffold bone implant (1)
- Scar (1)
- Scedosporium (1)
- Schenkelhernie (1)
- Schiff base chemistry (1)
- Schistosomiasis (1)
- Schizophrenie (1)
- Schlafbruxismus (1)
- Schlaganfall-Netzwerk (1)
- Schmerzchronifizierung (1)
- Schmerztherapie (1)
- Schmerzzeichnung (1)
- Schultergelenk (1)
- Schultergelenksinfektion (1)
- Schwangerschaft (1)
- Schädigungspotenzial (1)
- Score (1)
- Secretion (1)
- Segmentation (1)
- Sekundärglaukom (1)
- Selbsteinschätzung (1)
- Senecionin (1)
- Seneciphyllin (1)
- Senile Demenz (1)
- Serotonin (1)
- Serotonindefizienz (1)
- Sertralin (1)
- Set Shifting (1)
- Simulation (1)
- Single‐Molecule Localization Microscopy (SMLM) (1)
- Sjögren’s syndrome (1)
- Skin (1)
- Sklerodermie (1)
- Skript (1)
- Sleep fragmentation (1)
- Sleeping Beauty Transposon System (1)
- Somatosensibel evozierte Potenziale des Nervus vagus (1)
- Sonic hedgehog (1)
- Speckle tracking (1)
- Spectrophotometer (1)
- Spektrophotometer (1)
- Sphingomyelinase (1)
- Sphingomyelinphosphodiesterase (1)
- Spielfilm (1)
- Spirometrie (1)
- Sporthalle (1)
- Sporttraumatologie (1)
- Sportverletzung (1)
- Sprungbein (1)
- St. Johanns Spital (1)
- Stammzellforschung (1)
- Staphylococcus aureus (1)
- Sterbehospiz (1)
- Sterblichkeit (1)
- Stereolithographie (1)
- Steriolithografie (1)
- Sterol O-Acyltransferasen (1)
- Sterol-O-Acyl transferases (1)
- Stiff-Person Syndrom (1)
- Stiff-person syndrome (1)
- Strahlenbiologie (1)
- Strahlensensibilität (1)
- Stress (1)
- Stroke Manager (1)
- Stroke-Unit (1)
- Stroma (1)
- Subarachnoidalblutung (1)
- Subjektive Krankheitswahrnehmung (1)
- Sublay (1)
- Substantia Nigra - Echogenität (1)
- Superagonistic antibody (1)
- Superradiance & subradiance (1)
- Sylvia Lack (1)
- Symptome (1)
- Synergy (1)
- Synuclein <alpha-> (1)
- Säugling (1)
- T cell activation (1)
- T cell engaging Antibody (1)
- T cell subpopulations (1)
- T-LGL-Leukämie (1)
- T-LGL-Zellen (1)
- T-Lymphozyt (1)
- T-Zell-Aktivierung (1)
- T-Zelle (1)
- T-cell (1)
- T-cell non-Hodgkin's lymphomas (1)
- T-cell transfer (1)
- T-cells (1)
- T-lymphocytes (1)
- TAVI (1)
- TB (1)
- TCS (1)
- TEER (1)
- TERT (1)
- TGF-alpha (1)
- TGF-ß3 (1)
- TGFβ signaling (1)
- TH2 Immunantwort (1)
- TIGIT (1)
- TIND (1)
- TLR7 (1)
- TLR8 (1)
- TNAP (1)
- TNF ligand superfamily (1)
- TNF receptor (TNFR) family (1)
- TNRSF (1)
- TRP channel (1)
- TTR knockdown (1)
- TTR stabilization (1)
- Talar fracture (1)
- Talaromyces (1)
- Talus (1)
- Talusfraktur (1)
- Tanzania (1)
- Technologie (1)
- Teilkrone (1)
- Telemedizin (1)
- Tet‐inducible system (1)
- Th1 cells (1)
- Th17 (1)
- Th9 (1)
- Thebain (1)
- Theranostik (1)
- Therapieadhärenz (1)
- Therapieresistenz (1)
- Therapieziel (1)
- Thorax (1)
- Thrombektomie (1)
- Tiermodell (1)
- Tinnitus (1)
- Totalendoprothese (1)
- Toxizität (1)
- Tp63 (1)
- Tr1 (1)
- Trabekulektomie (1)
- Trabekulotomie (1)
- Training (1)
- Transarterielle Chemoembolisation (1)
- Transcription (1)
- Transfusionsrate (1)
- Transkranielle Sonographie (1)
- Transkranieller Ultraschall (1)
- Transkriptionsfaktor (1)
- Transmissionsgrad (1)
- Transposon (1)
- Treg (1)
- Trend (1)
- Triple co-culture (1)
- Triton X 100 (1)
- Trophic Factors (1)
- Troponin (1)
- Tryptophanstoffwechsel (1)
- Tuberculosis (1)
- Tumor (1)
- Tumor Microenvironment (1)
- Tumor-Nekrose-Faktor <alpha-Inhibitor> (1)
- Tumorwachstum (1)
- Tumorzelllinien (1)
- Turkish (1)
- Typ-2-Diabetes-mellitus (1)
- Type 1 diabetes (1)
- UKZ (1)
- USP25 (1)
- USP28 (1)
- USP8 (1)
- UV-Strahlung (1)
- UV-VIS-Spektroskopie (1)
- Ultrahochfeldmagnetresonanztomographie (1)
- Ultraschall-Elastographie (1)
- Ultraschallgeführte Biopsie (1)
- Ultraschallgesteuert (1)
- Umbilikalhernie (1)
- Umfrage (1)
- Umfragestudie (1)
- Unfallchirurgie (1)
- Unishunt (1)
- Uptake-1 (1)
- VLA-1 (1)
- VLSM (1)
- VPP mouse model (1)
- VSB (1)
- VSOP (1)
- Venlafaxin (1)
- Venoarteriell (1)
- Verfärbung (1)
- Verlegung <Ortswechsel> (1)
- Verletzung (1)
- Versorgungsstrategien (1)
- Vestibularisschwannom (1)
- Viabilität (1)
- Vibrant Soundbridge (1)
- Vif (1)
- Viktoriaseeregion (1)
- Vitamin D Mangel (1)
- Vitamin D-Mangel (1)
- Vitrektomie (1)
- Vokalisierung (1)
- Vollständigkeit (1)
- Volumentherapie (1)
- Volumetric modulated arc therapy (1)
- Vorhofohramputation (1)
- Vorläuferzelle (1)
- Vorsprachliche Diagnostik (1)
- WBC (1)
- WSS (1)
- WST test (1)
- Waldeyer’s tonsillar ring (1)
- Wandschubspannung (1)
- Wearable (1)
- Weinlaute (1)
- Weiße Fettzelle (1)
- Werner Bohndorf (1)
- Western blot (1)
- Wiederbelebung (1)
- Wilm's tumor (1)
- Wilms tumor (1)
- Winkelstabile Platte (1)
- Wirkstofffreisetzung (1)
- Wissenschaftskompetenz (1)
- Wnt (1)
- Wurmfortsatzentzündung (1)
- Wurzelkanalobliteration (1)
- X-ray crystallography (1)
- XAV-939 (1)
- YB-1 (1)
- Yoga (1)
- Zahnerhaltung (1)
- Zahnmedizinische Ausbildung (1)
- Zahnmedizinstudierende (1)
- Zelladhäsion (1)
- Zellforschung (1)
- Zellkulturmodell (1)
- Zellzyklus (1)
- Zementpaste (1)
- Zirkoniumdioxid (1)
- Zucker fatty fa/fa rats (1)
- [18F]FDG PET/CT (1)
- [18F]FDG-PET-CT (1)
- [\(^{223}\)Ra]RaCl\(_{2}\) (1)
- [\(^{68}\)Ga] Pentixafor (1)
- abdominal lymph node metastases (1)
- accessibility (1)
- acculturation (1)
- accuracy and precision (1)
- acetic acid (1)
- acetonitrile (1)
- acetylsalicylic acid (1)
- acid (1)
- acid sphingomyelinase (1)
- acinic cell carcinoma (1)
- actigraphy (1)
- actin messenger RNA (1)
- acupressure (1)
- acute ITP (1)
- acute Respiratory Distress Syndrome (1)
- acute appendicitis (1)
- acute graft-versus host disease (1)
- acute graft-versus-host disease (1)
- acute ischemic stroke (1)
- acute respiratory distress syndrome (ARDS) (1)
- acute toxicity (1)
- adaptive directional microphone setting (1)
- adaptive immune response (1)
- adaptive radiotherapy (1)
- adenoid cystic carcinoma (ACC) (1)
- adenylate cyclase toxin (1)
- adherence (1)
- adipose tissue (1)
- adipose tissue-derived stromal cells (1)
- adjuvant (1)
- adjuvant platinum-based chemotherapy (1)
- admission screening (1)
- adolescent (1)
- adolescents (1)
- adoptive cell therapy (1)
- adrenal crisis (1)
- adrenal incidentaloma (1)
- adrenal insufficiency (1)
- adrenal tumors (1)
- adrenocortical cancer (1)
- adrenocortical cell line (1)
- adrenocortical tissues (1)
- adrenocortical tumors (1)
- adults with congenital heart disease (1)
- adverse drug reactions (1)
- adverse pulmonary outcomes (1)
- aerobic threshold (1)
- afatinib (1)
- affective computing (1)
- age (1)
- age differences (1)
- age-related hearing loss (1)
- age-related macular degeneration (1)
- age-related macular degeneration (AMD) (1)
- agency (1)
- aging and cell death (1)
- agreeableness (1)
- airway epithelia (1)
- akute Herzinsuffizienz (1)
- akutes Nierenversagen (1)
- albumin (1)
- algorithm (1)
- alkaline phosphatase (1)
- allelic replacement (1)
- allergy (1)
- allosteric modulation (1)
- alpha-7 nicotinic acetylcholine receptor (1)
- alpha-synuclein (1)
- alpha‐synuclein (1)
- alpha‐synuclein propagation (1)
- alpha‐synuclein seeding (1)
- alternative methods (1)
- aluminum granuloma (1)
- alveolar bone (1)
- alveolar bone loss (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- alveolar ridge augmentation (1)
- alveolar‐capillary barrier (1)
- alzheimer's disease (1)
- amino acid (1)
- amino acid analogues (1)
- aminoacyl‐tRNA synthetases (1)
- amniotic infection (1)
- amoeboid cell migration (1)
- amplitude criterion (1)
- amyloid cardiomyopathy (1)
- amyloid-β (Aβ) (1)
- amyloid‐directed antibodies (1)
- amyotrophe Lateralsklerose (1)
- amyotrophic lateral sclerosis (ALS) (1)
- analgesia (1)
- analgesics (1)
- androgen deprivation therapy (1)
- anergy (1)
- aneurysmal subarachnoid hemorrhage (1)
- aneurysms (1)
- angiographische Embolsation der Arteria sphenopalatina (1)
- animal experimentation (1)
- animal study (1)
- anisotropic porous structures (1)
- ant brain (1)
- antenatal inflammation (1)
- anterior approach (1)
- anthocyanins (1)
- anti-TNFRSF receptor (TNFR) antibodies (1)
- anti-depressive treatment (1)
- anti-myocardial (1)
- antibacterial activity (1)
- antibiotic prescription (1)
- antibiotic prescription behavior (1)
- antibiotic resistance (1)
- antibiotic therapy (1)
- antibiotic use (1)
- antibiotics (1)
- antibodies (1)
- antibody (1)
- anticancer activity (1)
- anticoagulant therapy (1)
- antidepressant (1)
- antidepressive Therapie (1)
- antiemetics (1)
- antifungal susceptibility (1)
- antigen loss (1)
- antigen processing and presentation (1)
- antigens (1)
- antimicrobials (1)
- antinuclear antibodies (1)
- antioxidant nutrients (1)
- antioxidative (1)
- antiproliferative (1)
- antisense RNA (1)
- antitermination (1)
- antiviral agents (1)
- antiviral treatment (1)
- anxiety disorders (1)
- anxiety intensity (1)
- anxiety sensitivity (1)
- aorta ring (1)
- aortic adventitia (1)
- aortic aneurysm (1)
- aortic arch (1)
- aortic valve disease percutaneous intervention (AVDP) (1)
- apatite nanoparticles (1)
- app (1)
- appendicitis (1)
- applied mathematics (1)
- applied physics (1)
- approved drugs (1)
- arginine metabolism (1)
- arrhythmogenic cardiomyopathy (1)
- arterial elasticity (1)
- arterial stiffening (1)
- arthrography (1)
- arthroplasty (1)
- articular chondrocytes (1)
- artifacts (1)
- artificial bones (1)
- asiatische Augen (1)
- assistive devices (1)
- asthma (1)
- asymptomatic screening (1)
- atlas‐based volumetry (1)
- atopic dermatitis (1)
- attachment (1)
- attention deficit hyperactivity disorder (1)
- attention deficit/hyperactivity disorder (1)
- attentional blink (1)
- attention‐deficit (1)
- attenuation of disease (1)
- audiometry (1)
- auditory pathway (1)
- augmentation (1)
- autoantibodies (1)
- autoantibody (1)
- autoimmunity (1)
- autologous (1)
- automation (1)
- automation & robotics (1)
- autonomic nervous system (1)
- avatars (1)
- avelumab (1)
- avulsion (1)
- axi-cel (1)
- bacterial counts (1)
- bacterial genetics (1)
- bacterial immune evasion (1)
- bacteriophage (1)
- baghdadite (1)
- balance (1)
- ball (1)
- barrier (1)
- barrier models (1)
- basal forebrain cholinergic neurons (1)
- basic (laboratory) research / science (1)
- behavior (1)
- behavior problems (1)
- beta-D-glucan (1)
- bibliometrics (1)
- biochemical relapse free survival (1)
- biodistribution (1)
- biodosimetry (1)
- biofabrication (1)
- biofilm regulation (1)
- biofluid (1)
- bioinformatic (1)
- bioinformatic clustering (1)
- bioinspired membrane (1)
- biological fluorescence (1)
- biological techniques (1)
- biomarker combination (1)
- biomarker of exposure (1)
- biomarker prediction (1)
- biomaterials (1)
- biomechanical (1)
- biomechanical evaluation (1)
- biomedical engineering and bioengineering (1)
- biomimetic 3D tissue model (1)
- bioprinting (1)
- biopsy (1)
- bioreactor culture (1)
- bipolar disorder (1)
- black yeast (1)
- bladder cancer (1)
- bleeding score (1)
- blood brain barrier (1)
- blood coagulation (1)
- blood nerve barrier (1)
- blood pressure (1)
- blood samples (1)
- blood-nerve barrier (1)
- blood–labyrinth barrier (1)
- body awareness (1)
- body mass index (1)
- bone (1)
- bone adaptation (1)
- bone augmentation (1)
- bone cement (1)
- bone regeneration (1)
- bone substitutes (1)
- bone tissue engineering (1)
- bone turnover (1)
- bortezomib (1)
- brain asymmetry (1)
- brain cancer (1)
- brain laterality (1)
- brain metastases (1)
- brain tumor (1)
- brain-retina axis (1)
- brainstem auditory evoked potentials (1)
- breast cancer model (1)
- bridging (1)
- brown adipose tissue (1)
- burn wound (1)
- butyrylcholinesterase (1)
- c-MYC (1)
- cGMP (1)
- cadherins (1)
- calcification (1)
- calcofluor white staining (1)
- calipered (1)
- cancer associated fibroblasts (1)
- cancer genomics (1)
- cancer of unknown primary (CUP) (1)
- cancer predisposition syndromes (1)
- cancer therapy (1)
- cancer types (1)
- cancer-associated fibroblast (1)
- cancer-induced bone disease (1)
- carbon fiber (1)
- cardiac MRI (1)
- cardiac function (1)
- cardiac imaging (1)
- cardiac rehabilitation (1)
- cardiac rehabilitation standards (1)
- cardiogenetics (1)
- cardioprotection (1)
- cardiovascular diseases (1)
- cardiovascular magnetic resonance (1)
- caregiver burden (1)
- carotid artery disease (1)
- cartilage defectex vivo model (1)
- cartilage defects (1)
- cartilage test system (1)
- cell counting (1)
- cell death (1)
- cell labeling (1)
- cell migration (1)
- cell morphology (1)
- cell proliferation (1)
- cell viability (1)
- cell wall (1)
- cell-based therapy (1)
- cell-free therapeutics (1)
- cell-matrix interaction (1)
- cement paste (1)
- cementoclasts (1)
- cementum (1)
- central auditory pathway (1)
- central complex (1)
- ceramics, glass, composites, natural materials (1)
- ceramide (1)
- cerebellum (1)
- cerebral ischemia (1)
- cerebral metastases (1)
- cerebropulmonary disease (1)
- cerebrovascular disorders (1)
- cervical spine (1)
- challenging behaviours (1)
- chaperone (1)
- checkpoint blocker (1)
- chemical similarity (1)
- chemokine receptor (1)
- chemoradiation (1)
- chemotherapy (1)
- chest-x-ray (1)
- childhood interstitial lung disease (1)
- children´s interstitial lung disease (chILD) lipoid pneumonia (1)
- cholesterol pneumonia (1)
- cholesterol pneumonitis (1)
- choline acetyltransferase (1)
- chondrocytes (1)
- chondrogenic differentiation (1)
- chordotonal organ (1)
- choroidal neovascularization (CNV) (1)
- chromosomal genes (1)
- chronic hepatitis C (1)
- chronic kidney disease (1)
- chronic rhinosinusitis (1)
- chronic stimulation (1)
- chylomicron (1)
- ciliostasis (1)
- circadian rhythms (1)
- circuits and circuit components (1)
- cisplatin resistance (1)
- classical conditioning (1)
- classification (1)
- claudin-12 (1)
- click chemistry (1)
- click-chemistry (1)
- clinical approach (1)
- clinical data warehouse (1)
- clinical malformations (1)
- clinical study (1)
- clinical trial (1)
- clonal hematopoiesis of indeterminate potential (1)
- closed head injury (1)
- closure AV fistula/AVM (CLAV) (1)
- cluster of differentiation (1)
- coagulase-negative staphylococci (1)
- coagulation (1)
- coagulation and hemostasis (1)
- cochlea implant (1)
- cochlear implant (1)
- coercive measures (1)
- cognition (1)
- cognitive function (1)
- cold pressor test (1)
- collagen (1)
- collagen membranes (1)
- collagen synthesis (1)
- collagen type I hydrogel (1)
- collateral circulation (1)
- colon cancer (1)
- color-coded (1)
- colorectal cancer (1)
- combinatorial drug predictions (1)
- commercial kits (1)
- common variable immunodeficiency (CVID) (1)
- communication training (1)
- communication-related self-efficacy (1)
- community settings (1)
- comorbidities (1)
- compaction (1)
- comparative genomics (1)
- comprehension (1)
- compressive load (1)
- computational chemistry (1)
- computed tomography (1)
- computer science (1)
- condition prediction (1)
- conduction disease (1)
- cone beam CT (1)
- cone-beamcomputed tomography (1)
- conforming (1)
- congenital adrenal hyperplasia (1)
- congenital heart-deffects (1)
- conservative treatment (1)
- contact-kinin system (1)
- continence mechanism (1)
- continent cutaneous urinary diversion (1)
- continuous performance task (CPT) (1)
- conversion (1)
- convolutional neural networks (1)
- coping strategies (1)
- copy-number variation (1)
- coracohumeral distance (1)
- coracohumeral impingement (1)
- corneal confocal microscopy (1)
- coronary artery bypass grafting (1)
- coronary artery disease (1)
- coronavirus disease 2019 (1)
- correction (1)
- corticosteroids (1)
- cortisol (1)
- cortisol-producing adenoma (1)
- course of recovery (1)
- craniovertebral junction (1)
- creatine kinase (1)
- critically ill patients (1)
- crowdsensing (1)
- crown-root fracture (1)
- crying (1)
- cushing's syndrome (1)
- custom made implant (1)
- cutaneous T-cell-lymphoma (1)
- cutaneous angiosarcoma (1)
- cutibacteria (1)
- cyclic adenosine monophosphate (1)
- cyclic mechanical stretch (1)
- cyclic stretch (1)
- cyclic testing (1)
- cysteine restriction (1)
- cysteine synthase inhibitor (1)
- cytogenetics (1)
- cytokine release (1)
- cytokine release syndrome (1)
- cytotoxicity (1)
- dSTORM (1)
- danio rerio (1)
- data analysis (1)
- data quality (1)
- datawarehousing (1)
- deafness (1)
- death (1)
- decision making (1)
- decreasing autonomy (1)
- deformable image registration (1)
- deformational cranial asymmetry (1)
- deformational plagiocephaly (1)
- degradable bone substitutes (1)
- degradable implant (1)
- degradation profile (1)
- demyelination (1)
- dendritic cells (1)
- dengue infections (1)
- dengue serotypes (1)
- dengue virus (1)
- dental development in children (1)
- dental education (1)
- dental hard tissue defects (1)
- dental implants (1)
- dental restorative procedures (1)
- dentale Keramik (1)
- depressive Symptome (1)
- depressive disorder (1)
- desmin (1)
- desmocollin-2 (1)
- desmoglein-2 (1)
- detection limits (1)
- determining gene-product (1)
- detrended fluctuation analysis (1)
- development (1)
- developmental disabilities (1)
- diabetes (1)
- diabetic cardiomyopathy (1)
- diabetic retinopathy (1)
- diastolic function (1)
- diet (1)
- differential expression (1)
- digital phenotyping (1)
- digital subtraction angiography (1)
- digital transformation of health and care (1)
- digitization (1)
- diode (1)
- direct cortical stimulation (1)
- directional deep brain stimulation (1)
- discoloration index (1)
- discrimination training (1)
- disease model (1)
- disease progression (1)
- disk herniation (1)
- diskontinuierlich (1)
- docking (1)
- dominant intraprostatic lesion (1)
- dose accumulation (1)
- dose evaluation (1)
- dose rate (1)
- dose to OARs (1)
- dosimetry, QA (1)
- double negative B cells (1)
- dovitinib (1)
- drillable bone cement (1)
- drug abuse (1)
- drug design (1)
- drug-delivery (1)
- dual-energy (1)
- duodenal atresia (1)
- duodenal obstruction (1)
- duodenale Obstruktion (1)
- duration (1)
- durotaxis (1)
- dystonia (1)
- e-learning (1)
- eating disorders (1)
- eculizumab (1)
- editorial board (1)
- edoxaban (1)
- education (1)
- efficacy (1)
- eicosanoids (1)
- einseitige Taubheit (1)
- ejection fraction (1)
- electrical impedance tomography (1)
- electrocardiography (1)
- electroencephalogram (EEG) (1)
- electroencephalography (1)
- electroencephalography (EEG) (1)
- electrohydrodynamics (1)
- electromagnetic navigation (1)
- electromagnetic tracking system (1)
- electromagnetics (1)
- electron cryo microscopy (1)
- electron cryo-microscopy (1)
- electron microscopy (1)
- electronic data capture (1)
- electronic health records (1)
- elektromagnetisches Trackingsystem (1)
- elotuzumab (1)
- embedded templating (1)
- embolism/thrombosis (1)
- emotion (1)
- emotional states (1)
- emotions (1)
- emphysema (1)
- employee stress (1)
- encapsulation (1)
- encephalitis lethargica (1)
- endocannabinoids (1)
- endocarditis (1)
- endochondral ossification (1)
- endodontic management (1)
- endodontics (1)
- endogenous pulmonary stem cells (1)
- endoribonuclease (1)
- endoscopic full thickness resection (eFTR) (1)
- endothelial cell infection (1)
- endovascular therapy (1)
- endurance exercise (1)
- endurance training (1)
- energy homeostasis (1)
- engraftment syndrome (1)
- enhanced recovery after surgery (1)
- enrichment (1)
- enteric glial cells (1)
- enteric nervous system (1)
- envelopment (1)
- environmental sound (1)
- enzyme replacement therapy (1)
- ependymoma (1)
- ephitelial cells (1)
- epidermis (1)
- epidural analgesia (1)
- epithelial markers (1)
- epithelial salivary gland (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- epitope mapping (1)
- erblicher Brustkrebs (1)
- erratum (1)
- esohypotropia (1)
- essential tremor (1)
- estrogen receptor (1)
- evans blue (1)
- event-related potentials-ERP (1)
- evidence (1)
- evidence‐based medicine (1)
- evolutionary genetics (1)
- evozierte Potentiale (1)
- exact matching (1)
- executive function (1)
- executive functions (1)
- exercise training (1)
- experimental stroke (1)
- expert opinion (1)
- exposition training (1)
- expression (1)
- external beam radiotherapy (EBRT) (1)
- extracellular matrix disorganisation (1)
- extracellular-regulated kinase 5 (1)
- extramedullary (1)
- extramedullary disease (1)
- extrapulmonary tuberculosis (1)
- extravascular lung water (1)
- extremities (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- extrusion-based 3D printing (1)
- eye infection (1)
- eye tracking (1)
- fNIRS (1)
- fabry disease (1)
- factor XII (1)
- familial DCM (1)
- familial amyloid polyneuropathy (FAP) (1)
- familial hemophagocytic lymphohistiocytosis (1)
- family (1)
- family physicians (1)
- farbkodierte DSA (1)
- farringtonite (1)
- fat absorption (1)
- fatal traumatic brain injury (1)
- fatty liver (1)
- fatty liver disease (1)
- fear conditioning (1)
- fear generalization (1)
- fear-relevant training (1)
- feature selection (1)
- feedback (1)
- female (1)
- ferroptosis (1)
- fever (1)
- fibers (1)
- fibroblast activation protein (1)
- fibromyalgia sydrome (1)
- fiducial registration error (1)
- filtrierende Glaukomoperation (1)
- filtrierende Trabekulotomie (1)
- finger-tapping task (1)
- fixed-angle plate (1)
- flow cytometry (1)
- flow dynamics (1)
- fluid simulation (1)
- fluorescence imaging (1)
- fluorescent recombinant vaccinia virus (1)
- fluoroscopy (1)
- follow up (1)
- follow-up (1)
- force behavior (1)
- forced swimming (1)
- fpVCT (1)
- fractionation membranev (1)
- fracture (1)
- fracture risk (1)
- fractures, bone (1)
- frailty (1)
- frameless systems (1)
- free flap surgery (1)
- fromative assessment (1)
- frontotemporal dementia (1)
- full-thickness resection device (FTRD) (1)
- fumaric acid esters (1)
- functional status (1)
- fundamental frequency (1)
- fundamental frequency variation (1)
- fungal infection (1)
- fungal infection model (1)
- fungal rhodopsins (1)
- fusion and fission (1)
- future directions (1)
- gRNA-only (1)
- galactomannan (1)
- galectin-1 (1)
- galectin-3 (1)
- galectin-9 (1)
- gametogenesis (1)
- gastric MALT lymphoma (1)
- gastric bypass (1)
- gastrointestinal infections (1)
- gastrointestinal tract (1)
- gender (1)
- gene (1)
- gene panel (1)
- gene prediction (1)
- gene therapy (1)
- gene × sex interaction (1)
- gene-environment interaction (1)
- general practitioner (1)
- genetic analysis (1)
- genetic code expansion (1)
- genetic markers (1)
- genetic modification (1)
- genetic risk (1)
- genetic variants (1)
- genetics (1)
- genital warts (1)
- genome (1)
- genome packaging (1)
- genome wide (1)
- genomics (1)
- genotoxicity (1)
- genotype (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- geographic information science (1)
- geometry (1)
- gephyrin (1)
- germanophone (1)
- germline mutation (1)
- gezielte Therapie (1)
- giant cell arteritis (1)
- gingival index (1)
- glial fibrillary acidic protein (1)
- glioblastoma (1)
- glomerular filtration rate (1)
- glucocorticoid excess (1)
- glucocorticoid replacement (1)
- glucose homeostasis (1)
- glucuronide (1)
- glycine receptor (1)
- glycine receptor autoantibodies (1)
- glycocalyx (1)
- glycoprotein receptor Ib (1)
- glycosphingolipids (1)
- graft survival (1)
- graft versus host disease (1)
- graviception (1)
- group discussions (1)
- guanosine (1)
- guided bone regeneration (1)
- guided bone regeneration (GBR) (1)
- guided tissue regeneration (1)
- guideline adherence (1)
- guidelines & recommendations (1)
- gut barrier (1)
- hACE2 (1)
- hMSC-TERT (1)
- habitual mandibular position (1)
- haemodialysis (1)
- haemoglobin (1)
- harmonization of SPECT/CT imaging (1)
- head and neck (1)
- head and neck cancer (1)
- head and neck squamous cell carcinoma (1)
- health care providers (1)
- health care service research (1)
- health economics (1)
- health insurance (1)
- health-related quality of life (HRQoL) (1)
- hearing preservation (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- heart rate (1)
- heart transplantation (1)
- heart valve repair (1)
- heart-brain axis (1)
- heavy eye (1)
- hemadsorption (1)
- hemangioma (1)
- hematology (1)
- hematopoietic (1)
- hematopoietic stem cell transplantation (1)
- hemolytic anemia (1)
- hemorrhagic transformation (1)
- hemostasis, (1)
- hepatitis B core protein (1)
- hepatitis B virus (1)
- hepcidin (1)
- heritability (1)
- hernia (1)
- herpes simplex virus (1)
- heterozygote (1)
- high blood pressure (1)
- high myopia (1)
- high performance liquid chromatography (1)
- high-dose-rate (HDR) brachytherapy (1)
- hippocampal (1)
- histologic findings (1)
- histomorphometry (1)
- home-based-rehabilitation (1)
- homeostasis (1)
- homing (1)
- homocysteine (1)
- horizontal gene transfer (1)
- host defense (1)
- host shutoff (1)
- host-pathogen interaction (1)
- host–pathogen interaction (1)
- huh6 (1)
- human (1)
- human airway mucosa tissue models (1)
- human behaviour (1)
- human biomonitoring (1)
- human genomics (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human induced pluripotent stem cell (hiPSC) (1)
- human mesenchymal stem cell (1)
- human nasal epithelial cells (1)
- human neutrophil elastase (HNE) (1)
- human papillomavirus (1)
- human respiratory epithelial cells (1)
- human trabecular bone decellularization (1)
- human tracheo-bronchial epithelial cells (1)
- human-centered design (1)
- human-computer interaction (1)
- humane mesenchymale Stammzellen (1)
- humans (1)
- hybrid polymers (1)
- hydraulic reactivity (1)
- hydrocortisone (1)
- hydrogel formation (1)
- hydrogels (1)
- hyperactivity disorder (1)
- hypercholesterolemia (1)
- hyperekplexia (1)
- hyperlipidemia (1)
- hyperoxia (1)
- hyperperfusion (1)
- hypersensitivity (1)
- hyponatremia (1)
- hypothalamic gene expression (1)
- hypoxanthine (1)
- hypoxic-ischemic encephalopathy (1)
- hypoxische Enzephalopathie (1)
- iMP (1)
- iPS cells (1)
- iPSC (1)
- iPSC-CMs (1)
- iiron transporter (1)
- ileocecal resection (1)
- image segmentation (1)
- image-guided programming (1)
- imaging TTE/TEE (ITTE) (1)
- imaging techniques (1)
- imaging the immune system (1)
- immersive interfaces (1)
- immune activation (1)
- immune check inhibitor (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune evasion (1)
- immune monitoring (1)
- immune system (1)
- immunity (1)
- immunization (1)
- immunoglobulin G (1)
- immunology (1)
- immunosuppression (1)
- immunotherapies (1)
- impedance aggregometry; WHOLE-BLOOD THROMBOELASTOMETRY; DEFINITION; DISEASE (1)
- in silico analysis (1)
- in vitro Kulturmodelle (1)
- in vitro Testsystem (1)
- in vitro cell‐stretch model (1)
- in vitro model (1)
- in vitro modeling (1)
- in vivo (1)
- in-situ hybridization (1)
- in-vitro-Modell (1)
- in-vitro-Testsysteme (1)
- in-vivo Micro-Computed Tomography (1)
- inappropriate prescription (1)
- inborn error of immunity (1)
- inborn errors of immunity (IEIs) (1)
- incidence (1)
- incisional hernia (1)
- indirect costs (1)
- induced pluripotent stem cells (1)
- induction regimen (1)
- inebilizumab (1)
- infantile Hämangiome (1)
- infantile neuronal ceroid lipofuscinosis (1)
- infants with deformational plagiocephaly (DP) (1)
- infection control (1)
- infection spread (1)
- infection surveillance (1)
- infections: pneumonia (1)
- infectious diseases (1)
- infectious diseases management (1)
- infectivity assays (1)
- inferior colliculus (1)
- inflammaging (1)
- inflammatory neuropathy (1)
- informal caregiving (1)
- informed consent (1)
- injury (1)
- injury severity score (1)
- innovative surgical methods (1)
- inosine (1)
- inositol hexaphosphate (1)
- inpatient rehabilitation (1)
- inpatients (1)
- insect brain (1)
- insect standard brain atlas (1)
- insert (1)
- insulin receptor (IR) (1)
- integration (1)
- intellectual disabilities (1)
- intensity distribution (1)
- intensity zones (1)
- intensity-modulated radiation therapy (1)
- interactome (1)
- interacts (1)
- intercellular junctions (1)
- interdisziplinäre Hämangiomsprechstunde (1)
- interferon γ (1)
- interferon-free (1)
- interleukin-6 (1)
- interleukin-9 (1)
- internal dosimetry (1)
- internal medicine (1)
- international multicenter comparison exercise (1)
- interphase gap (1)
- interpulse interval (1)
- intestinal barrier (1)
- intestinal microbiota (1)
- intestine (1)
- intonation (1)
- intra-individual variability (IIV) (1)
- intraindividual comparison (1)
- intraoperative Ankopplungseffizienz (1)
- intraoperative monitoring (1)
- intravenous immunoglobulins (1)
- invasive fungal infection (1)
- invasiveness (1)
- inzisionale Hernie (1)
- ion channel (1)
- ipilimumab (1)
- iron dyshomeostasis (1)
- iron in parkinsonism (1)
- iron model (1)
- iron oxide nanoparticles (1)
- iron pathology (1)
- iron responisve element (1)
- ischemia (1)
- ischemia/reperfusion injury (1)
- ischemic penumbra (1)
- islet transplantation (1)
- isokinetics (1)
- iterative shape averaging (1)
- joint aspiration (1)
- joint infection (1)
- joint instability (1)
- journal (1)
- junctions (1)
- juvenile idiopathic arthritis (1)
- kardiogener Schock (1)
- keratinocytes (1)
- keratitis (1)
- ketogenic diet (1)
- kidney cancer (1)
- kinase inhibitors (1)
- kindliche Zahnentwicklung (1)
- knee joint (1)
- knowledge (1)
- kolorektales Karzinom (1)
- kommunikationsbezogene Selbstwirksamkeit (1)
- konservative Therapie (1)
- kontinuierlich und patientenkontrolliert (1)
- konventionelle Trabekulektomie (1)
- kutan (1)
- lactation (1)
- lactosylceramide alpha-2,3-sialyltransferase (ST3GAL5) (1)
- language acquisition (1)
- laparoscopic appendectomy (1)
- laparoscopy (1)
- large B-cell lymphoma (1)
- large cell transformation (1)
- large granular lymphocyte (1)
- large‐scale data (1)
- laryngeal tuberculosis (1)
- lasiocarpine (1)
- lasso regression (1)
- late thrombectomy (1)
- latency (1)
- lateral augmentation (1)
- lateral skull base (1)
- learning (1)
- left ventricular ejection fraction (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular mass (1)
- left ventricular remodeling (1)
- left ventricular thrombusv (1)
- left-ventricular function (1)
- leitlinienorientierte Therapie (1)
- lenalidomide-refractory patients (1)
- leptin (1)
- leptin system (1)
- lesion symptom mapping (1)
- lethality rate (1)
- leucocyte count (1)
- leukocytes (1)
- lifestyle (1)
- light-sensitive anion channel (1)
- linea alba (1)
- linear regression analysis (1)
- lipids (1)
- lipoblastoma (1)
- lipodystrophy (1)
- lipoid pneumonitis (1)
- lipoprotein apheresis (1)
- lipoprotein(a) (1)
- liquid chromatography tandem mass spectrometry (LC-MS/MS (1)
- liquid chromatography/mass spectrometry (1)
- lithium (1)
- liver metastasis (1)
- load to failure testing (1)
- local control (1)
- local drug delivery (1)
- locator (1)
- locomotion (1)
- loneliness (1)
- long-term effects (1)
- long-term quality (1)
- longitudinal magnetic resonance imaging (1)
- longitudinal studies (1)
- longitudinal study (1)
- loss-of-function (1)
- low back pain (1)
- low carb diet (1)
- low profile (1)
- low-secretion phenotype mutants (1)
- lung (1)
- lung cancer (1)
- lung cell model (1)
- lung fibrosis (1)
- lung function (1)
- lymph node metastases (1)
- lymph node stromal cells (1)
- lymph node transplantation (1)
- lymph node tuberculosis (1)
- lymphoid hyperplasia (1)
- lymphoma (1)
- mTOR (1)
- macrophage migration inhibitory factor (MIF) (1)
- magnesium (1)
- magnetic compass (1)
- mandibular advancement (1)
- mandibular resting position (1)
- mandibular shift (1)
- manufacturing (1)
- mapping (1)
- mass cytometry (1)
- mass spectronomy (1)
- massagetherapy (1)
- masticatory muscles (1)
- masticatory system (1)
- mastocytosis (1)
- maternal stress (1)
- maturation signal (1)
- mavacamten (1)
- measles (1)
- mechanical activation (1)
- mechanical loading (1)
- mechanism (1)
- mechanoresponsive Elemente (1)
- mechanoresponsive elements (1)
- medaka (1)
- media-based (1)
- medial ganglionic eminence (1)
- medial patellofemoral ligament (1)
- medial stabilized (1)
- median and dorsal raphe (1)
- medical analytics (1)
- medical device regulation (1)
- medical device software (1)
- medical research (1)
- medical-themed feature films (1)
- medikamentöse Sekundärprävention bei stroke (1)
- meiosis (1)
- melatonin (1)
- melt electrowriting (1)
- melt electrofibrillation (1)
- melt electrospinning writing (1)
- membrane trafficking (1)
- men (1)
- meninges (1)
- menopause (1)
- mental disorders (1)
- mental health (1)
- mental health monitoring (1)
- mental illness (1)
- mercapturic acid (1)
- mesencephalic locomotor region (1)
- mesenchymal markers (1)
- mesenteric lymph node (1)
- metabolic glycoengineering (1)
- metabolome (1)
- metabolomic profiling (1)
- metabolomics (1)
- metagenomics (1)
- metastasis (1)
- metastasis-directed therapy (1)
- metastatic (1)
- methylphenidate (1)
- miR-182-5p (1)
- miR-183 cluster (1)
- miR-30 (1)
- miRNA (1)
- miRNA processing (1)
- microanastomosis (1)
- microbial rhodopsins (1)
- microbiology (1)
- microbiology techniques (1)
- microfibers (1)
- microfluidics (1)
- microscopy (1)
- microvasculature (1)
- middle aged (1)
- middle cerebral artery occlusion (1)
- migration (1)
- mimetic peptide (1)
- mind-body intervention (1)
- mind–body intervention (1)
- mineralization (1)
- minimal invasive anterior approach (1)
- minimal invasiver anteriorer Zugangsweg (1)
- minimal-invasiv (1)
- minimalinvasiv (1)
- minimalinvasive (1)
- minimally invasiv (1)
- minimally invasive (1)
- minimum reporting standards (1)
- mitochondria (1)
- mitochondrial DNA (1)
- mitogen-activated protein kinase (1)
- mitotane (1)
- mixed methods (1)
- mobile application (1)
- mobile crowdsensing (1)
- mobile health (1)
- modified Rodnan skin score (mRSS) (1)
- modified monosaccharides (1)
- modular tumor tissue models (1)
- mold exposure (1)
- molecular alterations (1)
- molecular biology (1)
- molecular diagnostics (1)
- molecular dynamics simulation (1)
- molecular modeling (1)
- molecular neuroscience (1)
- molecular radiotherapy (MRT) (1)
- monoclonal antibody (1)
- monolayer (1)
- morbidity (1)
- morphological features (1)
- morphology controls (1)
- mortality/survival (1)
- mossy fiber synapses (1)
- motor control (1)
- motor learning (1)
- motor skill learning (1)
- motor training (1)
- mouthrinse (1)
- mtDNA (1)
- multicenter study (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- multimodal (1)
- multimodal therapy (1)
- multimodal treatments (1)
- multiparametric CT (1)
- multiparametric magnetic resonance imaging (1)
- multiple system atrophy (1)
- multisensorische Integration (1)
- multi‐organ disease (1)
- muscle dislocation (1)
- muscle-invasive bladder cancer (1)
- musculoskeletal diseases (1)
- mutation screening (1)
- mutation triggers (1)
- mutations (1)
- myasthenia (1)
- mycosis fungoides (1)
- mycotoxin (1)
- myelin (1)
- myelin barrier (1)
- myeloid (1)
- myeloid cells (1)
- myeloid-derived suppressor cells (MDSCs) (1)
- myeloma (1)
- myocardial aging (1)
- myocardial perfusion (1)
- myocardial work (1)
- myocardial work efficiency (1)
- myocarditis (1)
- myofilament proteins (1)
- myosin (1)
- naive T-cell gene editing (1)
- nanocarrier (1)
- nanoparticles (1)
- nasal polyps (1)
- natamycin (1)
- natriuretic peptide (1)
- natural killer cells (1)
- navigation (1)
- negative affect (1)
- negative pressure wound therapy (1)
- neovascular glaucoma (1)
- neovascularization, physiologic (1)
- nephroblastoma (1)
- nephroblastomatosis (1)
- nephrology (1)
- nerve biopsy (1)
- nerve tumor (1)
- nervous system (1)
- netrin-1 (1)
- network biology (1)
- network meta-analysis (1)
- network pharmacology (1)
- neural progenitor cells (1)
- neuralgic amyotrophy (1)
- neurite growth (1)
- neuroanatomy (1)
- neurocritical care (1)
- neurodevelopment (1)
- neurodevelopmental disorders / genetics (1)
- neuroendocrine neoplasms (NEN) (1)
- neuroendocrine tumor (1)
- neuroendocrine tumor (NET) (1)
- neuroendocrine tumors (NET) (1)
- neurofibromatosis type 2 (1)
- neuroleukemiosis (1)
- neurological (1)
- neurological complications (1)
- neurological examination (1)
- neurology (1)
- neuromelanin (1)
- neuromyelitis optica spectrum disorders (1)
- neuronal electrodes (1)
- neuronal maturation (1)
- neuronal networks (1)
- neuronal oscillations (1)
- neuropathic pain (1)
- neuropathology (1)
- neuropils (1)
- neuroprotective pathways (1)
- neuropsychiatric disorders (1)
- neuroradiology (1)
- neurorehabilitation (1)
- neuroscience (1)
- neurosphere (1)
- neurospheres (1)
- neurotoxicity (1)
- neurotrophic factors (1)
- neutrophil transmigration (1)
- newborn hearing screening (1)
- newborn infants (1)
- newly diagnosed ITP (1)
- nitrate and thyroid carcinogenesis (1)
- nitric oxide (1)
- nivolumab (1)
- nnU-net (1)
- nociception (1)
- node of Ranvier (1)
- nodular lymphcyte (1)
- noise measurement (1)
- nomogram (1)
- non-small cell lung cancer (1)
- noncoding RNA (1)
- norepinephrine transporter (1)
- normal adrenal glands (1)
- nuclear medicine (1)
- nuclear medicine therapy (1)
- nuclear ribonucleoprotein-R (1)
- nutrient supplementation (1)
- object recognition memory (1)
- objective structured clinical examination (1)
- ochratoxin A (1)
- octenidine (1)
- off label use (1)
- old age depression (1)
- old patients (1)
- older adults (1)
- olecranon (1)
- oligmometastases (1)
- oligorecurrence (1)
- olive (1)
- omecamtiv mecarbil (1)
- on-site examination (1)
- open appendectomy (1)
- open wound treatment (1)
- open-source epidermis (1)
- operative Verjüngung (1)
- oppositional-defiant disorder (1)
- optic nerve sheath diameter (1)
- oral anticancer drugs (1)
- oral mucosa model (1)
- oral potentially malignant disorders (1)
- orale Chemotherapie (1)
- organ toxicity (1)
- organoids (1)
- orthodontic forced eruption (1)
- orthopaedics (1)
- osimertinib (1)
- osseointegration (1)
- osteoclasts (1)
- osteogenesis (1)
- otology (1)
- outcomes (1)
- outpatient (1)
- outpatients (1)
- overdenture (1)
- overview (1)
- oxidation (1)
- oxidized phospholipids (1)
- p-Glykoprotein (1)
- pCa (1)
- paediatrics (1)
- pain chronification (1)
- pain therapy (1)
- pan-RCC (1)
- pancreatic head cancer (1)
- panel sequencing (1)
- parathyroid carcinoma (1)
- parent-child interaction therapy (PCIT) (1)
- parkinson’s disease (1)
- parotid gland (1)
- partial crown (1)
- particle study (1)
- passive data (1)
- patch clamp recording (1)
- patella alta (1)
- patella dislocation (1)
- patella instability (1)
- pathogenesis (1)
- pathogens (1)
- pathological staging (1)
- pathology (1)
- pathophysiological mechanisms (1)
- pathophysiology (1)
- patient blood management (1)
- patient outcome (1)
- patient satisfaction (1)
- patient specific implant (1)
- patient survival (1)
- patient triage (1)
- patients with multiple myeloma (1)
- pattern (1)
- pediatric adrenocortical adenoma (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical tumor (1)
- pediatric immune thrombocytopenia (1)
- pediatric thyroid cancer after Chernobyl and Fukushima (1)
- pediatrician (1)
- pedobarography (1)
- pelvic discontinuity (1)
- pembrolizumab (1)
- peptide (1)
- peptide immobilization (1)
- peptide inhibitor of envelopment (1)
- peptide microarray (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY3-36) (1)
- perception (1)
- percutaneous valve therapy (PVT) (1)
- perfusion bioreactor (1)
- perfusion imaging (1)
- perfusion-based bioreactor system (1)
- pericardiocentesis (1)
- periodontitis (1)
- perioperative care (1)
- perioperative management (1)
- peripheral artery disease (1)
- peripheral nervous system (1)
- peripheral neuropathy (1)
- periprosthetic infection (1)
- periprothetische Infektion (1)
- perivesical extension (1)
- permeability (1)
- permeability imaging (1)
- peroxisomes (1)
- personalized antimicrobial therapy (1)
- personalized medicine (1)
- phage (1)
- phagosome maturation (1)
- phantom (1)
- pharmacoepidemiology (1)
- pharmacogenomics (1)
- pharmacokinetics (1)
- phase conversion (1)
- phenprocoumon (1)
- photoreceptor (1)
- photothrombotic stroke (1)
- physiology (1)
- physiotherapy (1)
- phytic acid (1)
- piperacillin/tazobactam (1)
- plaque assay (1)
- plaque characteristics (1)
- plaque index (1)
- plaque isolation (1)
- plasma cell disorder (1)
- plasma cells (1)
- plasma membrane (1)
- plasmid-chromosome crosstalk (1)
- plasticity (1)
- plate (1)
- platelet factor 4 (1)
- platelet receptors (1)
- platform (1)
- pocket factor (1)
- point of care testing (1)
- polarized training (1)
- pollen tube (1)
- polyadenylation (1)
- polymer sciences (1)
- polymeric matrix (1)
- polymicrobial infection (1)
- polymyalgia rheumatica (1)
- polyneuropathy (1)
- polytrauma (1)
- polyurethane (1)
- pomalidomide (1)
- population coverage (1)
- population-based (1)
- positional plagiocephaly (1)
- positionalskull deformities (1)
- positron emission tomography/computed tomography (1)
- post mortem biochemistry (1)
- post-operative antibiotic treatment (1)
- post-traumatic stress disorder (1)
- postencephalitic parkinsonism (1)
- posteriore Komponentenseparation (1)
- postmortem biochemistry (1)
- postoperative pain (1)
- postural stability (1)
- pouch (1)
- power grids (1)
- pre-analytical variation (1)
- precision medicine (1)
- preclinical PET (1)
- preclinical imaging (1)
- preclinical research (1)
- preconditioning (1)
- precursor symptoms (1)
- predictive coding (1)
- predictive factor (1)
- pregnancy (1)
- prematurity (1)
- premixed (1)
- preoperative localization (1)
- presynaptic plasticity (1)
- preterm (1)
- preterm birth (1)
- prevalence (1)
- preventive treatment (1)
- primary biliary cholangitis (1)
- primary healthcare (1)
- primary immunodeficiency (1)
- primary progressive aphasia (1)
- primär ventrale Hernie (1)
- primäre Kniegelenksendoprothese (1)
- pro-inflammatory cytokines (1)
- pro-oxidant (1)
- professional (1)
- progenitor (1)
- prognosis (1)
- prognostic biomarker (1)
- prognostic factors (1)
- prognostic tools (1)
- progression (1)
- prolonged cytopenia (1)
- promoter-proximal pausing (1)
- prostate Imaging Reporting and Data System (1)
- prostate-specific membrane antigen (1)
- prostate-specific membrane antigen (PSMA) (1)
- protease inhibitors (1)
- protein (1)
- protein kinase D2/PKD2/PRKD2 (1)
- protein kinase a (1)
- protein kinases (1)
- proton channel (1)
- prämenstruell (1)
- präoperative Anämie (1)
- pseudofracture (1)
- pseudolymphoma (1)
- psychiatric disorders (1)
- psychische Belastung (1)
- psycho-geriatrics (1)
- psychogeriatrics (1)
- psychological interventions (1)
- psychological support (1)
- psychosocial resilience (1)
- public health (1)
- public mental health (1)
- pulmonary arteries (1)
- pulmonary edema (1)
- pulmonary rehabilitation (1)
- pulsatil (1)
- pulse wave velocity (1)
- pulssynchron (1)
- purmorphamine (1)
- pyrazolo[3,4-d]pyrimidine (1)
- qPCR (1)
- quality indicators (1)
- quality of life (QoL) (1)
- quality of live (1)
- quantitative SPECT/CT (1)
- questionnaire (1)
- r-TAPP (1)
- radiation therapy (1)
- radical resection (1)
- radiculopathy (1)
- radiobiology (1)
- radiography (1)
- radioligand therapy (1)
- radionuclide therapy (1)
- radiopharmaceuticals (1)
- radiotherapy (1)
- raman spectroscopy (1)
- randomized controlled double-blind study (1)
- rapid prototyping (1)
- rare mendelian disorders (1)
- ravulizumab (1)
- real-time PCR (1)
- recall antigen (1)
- receptor cluster (1)
- reconstruction (1)
- recovery (1)
- rectal cancer (1)
- rectum (1)
- recurrence free survival (1)
- recurrence-free survival (1)
- refugee healthcare (1)
- regenerative capacity (1)
- regenerative medicine/tissue engineering (1)
- regionalization and organoids (1)
- regulatory T cells (1)
- rehabilitation (1)
- release (1)
- remdesivir (1)
- reminder e-mails (1)
- renal (1)
- renal cell carcinoma (1)
- renal failure (1)
- renal function (1)
- repair (1)
- repeat surgery (1)
- repeated surgery (1)
- reporting and data system (1)
- reproducibility of results (1)
- repulsive guidance molecule A (1)
- residential institutions (1)
- resilience (1)
- resistance (1)
- response (1)
- resveratrol (1)
- retinitis pigmentosa (1)
- retinoic acid (1)
- retromuskuläres Netz (1)
- retroperitoneal tumor (1)
- retrorektus Netz (1)
- retrospective (1)
- retrotransposons (1)
- retroviral vectors (1)
- reveals (1)
- review (1)
- revision hip (1)
- revisional surgery (1)
- rheumatoid arthritis (1)
- rhinitis (1)
- rhodopsin (1)
- right heart impairment (1)
- right ventricular dysfunction (1)
- rising incidence of thyroid cancer (1)
- risk (1)
- risk factors and etiology (1)
- risk of fall (1)
- risk stratification (1)
- risk factor analysis (1)
- robotische Leistenhernienversorgung (1)
- root resorption (1)
- root-canal treatment (1)
- rotator cuff tear (1)
- rubber hand illusion (1)
- rumenic acid (1)
- rygb (1)
- sacrificial printing (1)
- safety (1)
- safety behavior (1)
- salivary (1)
- salivary glands (1)
- salvage (1)
- sample size calculation (1)
- satisfaction with life (1)
- satralizumab (1)
- scaffold search (1)
- schablonengeführte Trepanation (1)
- sciatic nerve (1)
- scientific competency (1)
- scientific publications (1)
- scleroderma (1)
- score (1)
- screening and overdiagnosis (1)
- second hit (1)
- second line therapy (1)
- secondary data usage (1)
- secondary skin closure (1)
- secondary stroke injury (1)
- sedentary behavior (1)
- selective outcome reporting (1)
- selen (1)
- self-assessmen (1)
- self-employed (1)
- self-help (1)
- semi-automatische Analyse (1)
- seminoma (1)
- senecionine (1)
- seneciphylline (1)
- senescence (1)
- sensitivity (1)
- sensitivity analysis (1)
- sepsis (1)
- serial block face EM (1)
- seroepidemiologic studies (1)
- serology (1)
- serotonin transporter deficient mice (1)
- serotonin-specific neurons (1)
- serum concentration (1)
- severe injury (1)
- sex determination (1)
- sex differences (1)
- shRNA (1)
- shear stress (1)
- shimming (1)
- sialic acid (1)
- sialyltransferase (1)
- signal transduction (1)
- signaling pathway (1)
- signalling (1)
- signs (1)
- signs and symptoms (1)
- silkworm (1)
- simultan integrierter Boost (1)
- simultaneous integrated boost (1)
- single strand blocking (1)
- sirolimus (1)
- skeletal mechanobiology (1)
- skin carcinogenesis (1)
- skin models (1)
- skin punch biopsy (1)
- skinned fiber (1)
- sky compass (1)
- sleep (1)
- sleep bruxism (1)
- slope (1)
- small RNAs (1)
- small business (1)
- small fiber neuropathy (1)
- small fiber pathology (1)
- smartphone communication (1)
- smoking cessation (1)
- social cognitive (1)
- social media use (1)
- social well-being (1)
- socioeconomic status (1)
- sodium-23 (1)
- soft tissue augmentation (1)
- solnatide (1)
- soluble guanylyl cyclase (1)
- solution electrospinning (1)
- somatic resilience (1)
- somatostatin receptor (1)
- somatostatin receptor (SSTR) (1)
- somatostatin receptor antagonists (1)
- spanlastic (1)
- spatiotemporal thrombus (1)
- speech discrimination (1)
- spherical (1)
- spheroids (1)
- sphingolipid (1)
- sphingomyelinase (1)
- sphingosine 1-phosphate (1)
- sphingosine-1-phosphate (1)
- spinal cord (1)
- spinal cord neurons (1)
- spinal tumor operation (1)
- spiral ganglion neuron (1)
- spironolactone (1)
- spleen (1)
- splicing (1)
- split-belt treadmill (1)
- squamous (1)
- standardization of SPECT/CT imaging (1)
- stanfieldite (1)
- startle disease (1)
- stem cells (1)
- stem-cell research (1)
- stereotactic body radiotherapy (1)
- stereotaxy (1)
- stiff person syndrome (1)
- strabismus fixus (1)
- strain rate (1)
- strain specificity (1)
- stress instructions (1)
- stress signaling (1)
- stroke networks (1)
- stroke unit (1)
- structural MRI (1)
- structural biology (1)
- structure-activity relationships (1)
- structure–activity (1)
- subarachnoid hemorrhage (SAH) (1)
- subgingival defects (1)
- subjective perception (1)
- subscapularis tear (1)
- substantia nigra (1)
- substituent (1)
- subthalamic nucleus (1)
- sudden cardiac death (1)
- sugar glass printing (1)
- super-resolution microscopy (SRM) (1)
- supplements (1)
- supportive care (1)
- surface modification (1)
- surface potential recording (1)
- surfaces and interfaces, thin films (1)
- surgical and invasive medical procedures (1)
- surgical complications (1)
- surgical intra-abdominal infections (1)
- surgical oncology (1)
- surgical outcome (1)
- surgical site infections (1)
- surgical therapy (1)
- surveillance (1)
- survival (1)
- survivors (1)
- sustained inflammation (1)
- swine (1)
- sympathetic nervous system (1)
- symptom-specific treatment (1)
- symptoms (1)
- synapse formation (1)
- synaptic plasticity (1)
- synaptische Plastizität (1)
- synbones (1)
- synovial fluid (1)
- synthesis (1)
- systematic investigations (1)
- systematic review, (1)
- systemic endotoxemia (1)
- tDCS (1)
- tandem mass spectrometry (1)
- target considerations (1)
- targeted metabolomics (1)
- task retention (1)
- tauopathy (1)
- tdcs (1)
- tele-medicine (1)
- telomeres (1)
- temporal bone (1)
- temporal information transfer (1)
- tension band wiring (1)
- term patterns (1)
- terminal ileitis (1)
- test system (1)
- testing strategy (1)
- tetrahydroisoquinoline derivates (1)
- therapeutic antibody (1)
- thermogenesis (1)
- thermophile (1)
- thin-layer chromatography (1)
- third-wave psychotherapy (1)
- thoracic cancer (1)
- thorax (1)
- three-dimensional (1)
- three-dimensional printing (1)
- threshold criterion (1)
- threshold level (1)
- thrombin (1)
- thromboelastometry (1)
- thromboemboli (1)
- thromboembolism (1)
- thromboinflammation (1)
- thromboxane (1)
- thymic epithelial tumor (1)
- thymitis (1)
- thymus (1)
- tibial head depression fracture (1)
- tics (1)
- tight junction proteins (1)
- time series (1)
- time-to-centrifugation (1)
- tissue model (1)
- tocilizumab (1)
- tolerability (1)
- tooth fracture (1)
- tooth injuries (1)
- topotaxis (1)
- total hip arthroplasty (1)
- trabectome (1)
- trabeculectomy (1)
- traceability of SPECT/CT imaging (1)
- tracheal cytotoxin (1)
- trained immunity (1)
- tranexamic acid (1)
- transanal endoscopic microsurgery (TEM) (1)
- transcatheter valveimplantation (TVI) (1)
- transcranial motor-evoked potentials (1)
- transcranial sonography (1)
- transcriptome (1)
- transcriptomics (1)
- transcutaneous auricular vagus nerve stimulation (1)
- transcutaneous cervical vagus nerve stimulation (1)
- transcutaneous vagus nerve stimulation (1)
- transfer learning (1)
- transformations (1)
- transgenic animals (1)
- transient ischemic attack (1)
- translational medical research (1)
- transplantation (1)
- transporter gene SLC2A3 (1)
- transposable elements (1)
- transthyretin (1)
- traumatic brain injury (1)
- treatment guidelines (1)
- treatment options (1)
- treatment resistance (1)
- treatment response (1)
- treatment strategy (1)
- treatment-induced neuropathy in diabetes (TIND) (1)
- tremor (1)
- trial registration (1)
- triangular fibrocartilage (1)
- trochlear dysplasia (1)
- troponin (1)
- tumor (1)
- tumor invasion front (1)
- tumor spheroids (1)
- tumor surveillance (1)
- tumor-vessel wall-interface model (1)
- tumors (1)
- tumour (1)
- tumour immunology (1)
- tunable ultra‐thin biphasic membrane (1)
- type I interferon (1)
- tyrosine kinase inhibitor (TKI) (1)
- tyrosine kinase inhibitors (1)
- uORF (1)
- ublituximab (1)
- ultra highfield magnetic resonance imaging (1)
- ultrahigh field (1)
- ultrahigh-field (1)
- ultrasound guided (1)
- ultrasound vocalizations (1)
- uncoupling protein 1 (1)
- unidirectional freezing (1)
- unmet needs (1)
- unsupervised clustering (1)
- upper extremity (1)
- urinary tract infections (1)
- urology (1)
- ursodeoxycholic acid (1)
- urämische Enzephalopathie (1)
- uveal melanoma (1)
- vaccination (1)
- vaccination campaign (1)
- vaccination hesitancy (1)
- vaccine (1)
- vaccine refusal (1)
- various cancer diseases (1)
- vascular (1)
- vascular biofabrication (1)
- vascular disease (1)
- vascular disturbances (1)
- vascular network and hierarchical organized vessels (1)
- vascular wall stem and progenitor cells (1)
- vascularization model (1)
- vasculature (1)
- vasculitis (1)
- vasculogenesis (1)
- venereology (1)
- ventilation (1)
- ventilatory threshold (1)
- ventrale Hernie (1)
- ventricular assist device (1)
- vesicle trafficking (1)
- vestibular schwannoma (1)
- veterinarians (1)
- veterinary medicine (1)
- viral (1)
- viral assembly (1)
- viral epidemiology (1)
- virology (1)
- virtual body ownership (1)
- virulence (1)
- virus (1)
- virus budding (1)
- virus entry (1)
- virus host interaction (1)
- virus reactivation (1)
- virus replication (1)
- viruses (1)
- virus–iron interaction (1)
- visual analytics (1)
- vitamin D (1)
- vitamin D deficiency (1)
- vitamin d (1)
- volatile anesthetics (1)
- volumetric absorptive microsampling (1)
- vomiting (1)
- von Economo (1)
- vorderer Zugang (1)
- vorgemischt (1)
- wave interference (1)
- weight gain (1)
- whole blood ex vivo model (1)
- whole breast irradiation (1)
- whole exome sequencing (1)
- wind compass (1)
- working memory (1)
- wound fluid (1)
- wound model (1)
- wound physiology (1)
- wrist (1)
- yoga (1)
- young patients (1)
- zeitlich Informationsübertragung (1)
- zinc (1)
- zinc cluster transcription factor (1)
- zinc oxide nanoparticles (1)
- zonal (1)
- Östrogene (1)
- Östrogenrezeptor (1)
- Überlebenszeitanalyse (1)
- ɑ-Synuclein and iron (1)
- ΔNp63 (1)
- α-Emitter (1)
- α-Synuclein (1)
- α-synuclein (1)
- α-tricalcium phosphate (1)
- β-catenin (1)
- γ-H2AX (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Medizinische Klinik und Poliklinik I (66)
- Medizinische Klinik und Poliklinik II (52)
- Theodor-Boveri-Institut für Biowissenschaften (50)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (49)
- Neurologische Klinik und Poliklinik (48)
- Graduate School of Life Sciences (40)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (38)
- Pathologisches Institut (36)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (35)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (32)
Schriftenreihe
Sonstige beteiligte Institutionen
- Klinikum Fulda (2)
- Apotheke, Universitätsklinikum Würzburg (1)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (1)
- Fraunhofer (1)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (1)
- Interdisciplinary Bank of Biological Material and Data Würzburg (IBDW) (1)
- Klinikum Main-Spessart Lohr (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship, Universitätsklinikum Würzburg (1)
- Lehrkrankenhaus II. Medizinische Klinik Klinikum Coburg (1)
Background
Deregulated expression of MYC is a driver of colorectal carcinogenesis, suggesting that decreasing MYC expression may have significant therapeutic value. CIP2A is an oncogenic factor that regulates MYC expression. CIP2A is overexpressed in colorectal cancer (CRC), and its expression levels are an independent marker for long-term outcome of CRC. Previous studies suggested that CIP2A controls MYC protein expression on a post-transcriptional level.
Methods
To determine the mechanism by which CIP2A regulates MYC in CRC, we dissected MYC translation and stability dependent on CIP2A in CRC cell lines.
Results
Knockdown of CIP2A reduced MYC protein levels without influencing MYC stability in CRC cell lines. Interfering with proteasomal degradation of MYC by usage of FBXW7-deficient cells or treatment with the proteasome inhibitor MG132 did not rescue the effect of CIP2A depletion on MYC protein levels. Whereas CIP2A knockdown had marginal influence on global protein synthesis, we could demonstrate that, by using different reporter constructs and cells expressing MYC mRNA with or without flanking UTR, CIP2A regulates MYC translation. This interaction is mainly conducted by the MYC 5′UTR.
Conclusions
Thus, instead of targeting MYC protein stability as reported for other tissue types before, CIP2A specifically regulates MYC mRNA translation in CRC but has only slight effects on global mRNA translation. In conclusion, we propose as novel mechanism that CIP2A regulates MYC on a translational level rather than affecting MYC protein stability in CRC.
Formation and treatment of biofilms present a great challenge for health care and industry. About 80% of human infections are associated with biofilms including biomaterial centered infections, like infections of prosthetic heart valves, central venous catheters, or urinary catheters. Additionally, biofilms can cause food and drinking water contamination. Biofilm research focusses on application of experimental biofilm models to study initial adherence processes, to optimize physico-chemical properties of medical materials for reducing interactions between materials and bacteria, and to investigate biofilm treatment under controlled conditions. Exploring new antimicrobial strategies plays a key role in a variety of scientific disciplines, like medical material research, anti-infectious research, plant engineering, or wastewater treatment. Although a variety of biofilm models exist, there is a lack of standardization for experimental protocols, and designing experimental setups remains a challenge. In this study, a number of experimental parameters critical for material research have been tested that influence formation and stability of an experimental biofilm using the non-pathogenic model strain of Pseudomonas fluorescens. These parameters include experimental time frame, nutrient supply, inoculum concentration, static and dynamic cultivation conditions, material properties, and sample treatment during staining for visualization of the biofilm. It was shown, that all tested parameters critically influence the experimental biofilm formation process. The results obtained in this study shall support material researchers in designing experimental biofilm setups.
Objectives
Micro-computed tomography (μ-CT) and histology, the current gold standard methods for assessing the formation of new bone and blood vessels, are invasive and/or destructive. With that in mind, a more conservative tool, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), was tested for its accuracy and reproducibility in monitoring neovascularization during bone regeneration. Additionally, the suitability of blood perfusion as a surrogate of the efficacy of osteoplastic materials was evaluated.
Materials and methods
Sixteen rabbits were used and equally divided into four groups, according to the time of euthanasia (2, 3, 4, and 6 weeks after surgery). The animals were submitted to two 8-mm craniotomies that were filled with blood or autogenous bone. Neovascularization was assessed in vivo through DCE-MRI, and bone regeneration, ex vivo, through μ-CT and histology.
Results
The defects could be consistently identified, and their blood perfusion measured through DCE-MRI, there being statistically significant differences within the blood clot group between 3 and 6 weeks (p = 0.029), and between the former and autogenous bone at six weeks (p = 0.017). Nonetheless, no significant correlations between DCE-MRI findings on neovascularization and μ-CT (r =−0.101, 95% CI [−0.445; 0.268]) or histology (r = 0.305, 95% CI [−0.133; 0.644]) findings on bone regeneration were observed.
Conclusions
These results support the hypothesis that DCE-MRI can be used to monitor neovascularization but contradict the premise that it could predict bone regeneration as well.
Objectives
To investigate plaque inhibition of 0.1% octenidine mouthwash (OCT) vs. placebo over 5 days in the absence of mechanical plaque control.
Materials and methods
For this randomized, placebo-controlled, double-blind, parallel group, multi-center phase 3 study, 201 healthy adults were recruited. After baseline recording of plaque index (PI) and gingival index (GI), collection of salivary samples, and dental prophylaxis, subjects were randomly assigned to OCT or placebo mouthwash in a 3:1 ratio. Rinsing was performed twice daily for 30 s. Colony forming units in saliva were determined before and after the first rinse. At day 5, PI, GI, and tooth discoloration index (DI) were assessed. Non-parametric van Elteren tests were applied with a significance level of p < 0.05.
Results
Treatment with OCT inhibited plaque formation more than treatment with placebo (PI: 0.36 vs. 1.29; p < 0.0001). OCT reduced GI (0.04 vs. placebo 0.00; p = 0.003) and salivary bacterial counts (2.73 vs. placebo 0.24 lgCFU/ml; p < 0.0001). Tooth discoloration was slightly higher under OCT (DI: 0.25 vs. placebo 0.00; p = 0.0011). Mild tongue staining and dysgeusia occurred.
Conclusions
OCT 0.1% mouthwash inhibits plaque formation over 5 days. It therefore can be recommended when regular oral hygiene is temporarily compromised.
Clinical relevance
When individual plaque control is compromised, rinsing with octenidine mouthwash is recommended to maintain healthy oral conditions while side effects are limited.
Despite successful recanalization of large-vessel occlusions in acute ischemic stroke, individual patients profit to a varying degree. Dynamic susceptibility-weighted perfusion and dynamic T1-weighted contrast-enhanced blood-brain barrier permeability imaging may help to determine secondary stroke injury and predict clinical outcome. We prospectively performed perfusion and permeability imaging in 38 patients within 24 h after successful mechanical thrombectomy of an occlusion of the middle cerebral artery M1 segment. Perfusion alterations were evaluated on cerebral blood flow maps, blood-brain barrier disruption (BBBD) visually and quantitatively on ktrans maps and hemorrhagic transformation on susceptibility-weighted images. Visual BBBD within the DWI lesion corresponded to a median ktrans elevation (IQR) of 0.77 (0.41–1.4) min−1 and was found in all 7 cases of hypoperfusion (100%), in 10 of 16 cases of hyperperfusion (63%), and in only three of 13 cases with unaffected perfusion (23%). BBBD was significantly associated with hemorrhagic transformation (p < 0.001). While BBBD alone was not a predictor of clinical outcome at 3 months (positive predictive value (PPV) = 0.8 [0.56–0.94]), hypoperfusion occurred more often in patients with unfavorable clinical outcome (PPV = 0.43 [0.10–0.82]) compared to hyperperfusion (PPV = 0.93 [0.68–1.0]) or unaffected perfusion (PPV = 1.0 [0.75–1.0]). We show that combined perfusion and permeability imaging reveals distinct infarct signatures after recanalization, indicating the severity of prior ischemic damage. It assists in predicting clinical outcome and may identify patients at risk of stroke progression.
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
(2021)
Background
The presence or future development of metastatic pheochromocytomas or paragangliomas (mPPGLs) can be difficult to diagnose or predict at initial presentation. Since production of catecholamines from mPPGLs is different from non-metastatic tumors (non-mPPGLs), this study aimed to clarify whether presenting catecholamine-related signs and symptoms (cSS) might also differ.
Methods
The study included 249 patients, 43 with mPPGL and 206 with non-mPPGL. Clinical data at the time of biochemical diagnosis (i.e. at entry into the study) were used to generate a cumulative score of cSS for each patient.
Results
Patients with mPPGL were significantly younger (43.3 ± 14 vs. 48.9 ± 16.1 years) and included a lower proportion of females (39.5% vs. 60.7%) than patients with non-mPPGLs. Frequencies of signs and symptoms did not differ between the two groups. Patients with mPPGLs had lower (P < 0.001) urinary excretion of epinephrine (3.5 (IQR, 1.9—6.5) µg/day) than those with non-mPPGLs (19.1 (IQR, 4.3—70.2) µg/day). There was no difference in urinary excretion of norepinephrine. In patients with mPPGLs a high cSS score was associated with high urinary excretion of norepinephrine and normetanephrine. In contrast, in patients with non-mPPGLs, a high cSS was associated with high urinary excretion of epinephrine and metanephrine.
Conclusion
Although presenting signs and symptoms were associated with production of norepinephrine in patients with mPPGLs and of epinephrine in patients with non-mPPGLs, there were no differences in signs and symptoms between the two groups. Therefore, consideration of signs and symptoms does not appear helpful for distinguishing patients with and without mPPGLs.
Purpose
The subclassification of adrenal cancers according to the WHO classification in ordinary, myxoid, oncocytic, and sarcomatoid as well as pediatric types is well established, but the criteria for each subtype are not sufficiently determined and the relative frequency of the different types of adrenal cancers has not been studied in large cohorts. Therefore, our large collection of surgically removed adrenal cancers should be reviewed o establish the criteria for the subtypes and to find out the frequency of the various types.
Methods
In our series of 521 adrenal cancers the scoring systems of Weiss et al., Hough et al., van Slooten et al. and the new Helsinki score system were used for the ordinary type of cancer (97% of our series) and the myxoid type (0.8%). For oncocytic carcinomas (2%), the scoring system of Bisceglia et al. was applied.
Results
Discrepancies between benign and malignant diagnoses from the first thee classical scoring systems are not rare (22% in our series) and could be resolved by the Helsinki score especially by Ki-67 index (more than 8% unequivocally malignant). Since all our cancer cases are positive in the Helsinki score, this system can replace the three elder systems. For identification of sarcomatoid cancer as rarest type in our series (0.2%), the scoring systems are not practical but additional immunostainings used for soft tissue tumors and in special cases molecular pathology are necessary to differentiate these cancers from adrenal sarcomas. According to the relative frequencies of the different subtypes of adrenal cancers the main type is the far most frequent (97%) followed by the oncocytic type (2%), the myxoid type (0.8%) and the very rare sarcomatoid type (0.2%).
Conclusions
The Helsinki score is the best for differentiating adrenal carcinomas of the main, the oncocytic, and the myxoid type in routine work. Additional scoring systems for these carcinomas are generally not any longer necessary. Signs of proliferation (mitoses and Ki-67 index) and necroses are the most important criteria for diagnosis of malignancy.
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis
(2021)
Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number of individuals with primary and secondary adrenal insufficiency in Europe is estimated to be 20–50/100.000. A growing number of AI cases are due to side effects of GC treatment used in different treatment strategies for cancer and to immunotherapy in cancer treatment. The benefit of hormone replacement therapy is evident but long-term adverse effects may arise due to the non-physiological GC doses and treatment regimens used. Given multiple GC replacement formulations available comprising short-acting, intermediate, long-acting and novel modified-release hydrocortisone as well as subcutaneous formulations, this review offers a concise summary on the latest therapeutic improvements for treatment of AI and prevention of adrenal crises. As availability of various glucocorticoid formulations and access to expert centers across Europe varies widely, European Reference Networks on rare endocrine conditions aim at harmonizing treatment and ensure access to specialized patient care for individual case-by-case treatment decisions. To improve the availability across Europe to cost effective oral and parenteral formulations of hydrocortisone will save lives.
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies
(2021)
Purpose
Survival in recurrent ependymoma (EPN) depends mainly on the extent of resection achieved. When complete resection is not feasible, chemotherapy is often used to extend progression-free and overall survival. However, no consistent effect of chemotherapy on survival has been found in patients with recurrent EPN.
Methods
Systemic chemotherapeutic treatment of 138 patients enrolled in the German HIT-REZ-studies was analyzed. Survival depending on the use of chemotherapy, disease-stabilization rates (RR), duration of response (DOR) and time to progression (TTP) were estimated.
Results
Median age at first recurrence was 7.6 years (IQR: 4.0–13.6). At first recurrence, median PFS and OS were 15.3 (CI 13.3–20.0) and 36.9 months (CI 29.7–53.4), respectively. The Hazard Ratio for the use of chemotherapy in local recurrences in a time-dependent Cox-regression analysis was 0.99 (CI 0.74–1.33). Evaluable responses for 140 applied chemotherapies were analyzed, of which sirolimus showed the best RR (50%) and longest median TTP [11.51 (CI 3.98; 14.0) months] in nine patients, with the strongest impact found when sirolimus was used as a monotherapy. Seven patients with progression-free survival > 12 months after subtotal/no-resection facilitated by chemotherapy were found. No definitive survival advantage for any drug in a specific molecularly defined EPN type was found.
Conclusion
No survival advantage for the general use of chemotherapy in recurrent EPN was found. In cases with incomplete resection, chemotherapy was able to extend survival in individual cases. Sirolimus showed the best RR, DOR and TTP out of all drugs analyzed and may warrant further investigation.
Purpose
Biallelic pathogenic NBAS variants manifest as a multisystem disorder with heterogeneous clinical phenotypes such as recurrent acute liver failure, growth retardation, and susceptibility to infections. This study explores how NBAS-associated disease affects cells of the innate and adaptive immune system.
Methods
Clinical and laboratory parameters were combined with functional multi-parametric immunophenotyping methods in fifteen NBAS-deficient patients to discover possible alterations in their immune system.
Results
Our study revealed reduced absolute numbers of mature CD56dim natural killer (NK) cells. Notably, the residual NK cell population in NBAS-deficient patients exerted a lower potential for activation and degranulation in response to K562 target cells, suggesting an NK cell–intrinsic role for NBAS in the release of cytotoxic granules. NBAS-deficient NK cell activation and degranulation was normalized upon pre-activation by IL-2 in vitro, suggesting that functional impairment was reversible. In addition, we observed a reduced number of naïve B cells in the peripheral blood associated with hypogammaglobulinemia.
Conclusion
In summary, we demonstrate that pathogenic biallelic variants in NBAS are associated with dysfunctional NK cells as well as impaired adaptive humoral immunity.
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
(2021)
The aim of the current review was to provide a new, in-depth insight into possible pharmacological targets of amantadine to pave the way to extending its therapeutic use to further indications beyond Parkinson’s disease symptoms and viral infections. Considering amantadine’s affinities in vitro and the expected concentration at targets at therapeutic doses in humans, the following primary targets seem to be most plausible: aromatic amino acids decarboxylase, glial-cell derived neurotrophic factor, sigma-1 receptors, phosphodiesterases, and nicotinic receptors. Further three targets could play a role to a lesser extent: NMDA receptors, 5-HT3 receptors, and potassium channels. Based on published clinical studies, traumatic brain injury, fatigue [e.g., in multiple sclerosis (MS)], and chorea in Huntington’s disease should be regarded potential, encouraging indications. Preclinical investigations suggest amantadine’s therapeutic potential in several further indications such as: depression, recovery after spinal cord injury, neuroprotection in MS, and cutaneous pain. Query in the database http://www.clinicaltrials.gov reveals research interest in several further indications: cancer, autism, cocaine abuse, MS, diabetes, attention deficit-hyperactivity disorder, obesity, and schizophrenia.
Mit der Entdeckung altersabhängiger epigenetischer Veränderungen, der DNA-Methylierung (DNAm), hat sich eine neue Möglichkeit aufgezeigt, das Alter eines Individuums zu schätzen. Die Methode wurde intensiv erforscht und ihre Anwendung in der forensischen Fallarbeit durch die Aktualisierung des § 81e der Strafprozessordnung (StPO) in Deutschland reguliert. Zur Untersuchung des DNAm-Grades müssen neue Techniken etabliert und validiert werden. Dies macht die Prüfung der Vergleichbarkeit von Messergebnissen aus verschiedenen forensischen Laboren erforderlich.
Hierzu führte die Arbeitsgruppe „Molekulare Altersschätzung“ der Deutschen Gesellschaft für Rechtsmedizin (DGRM) im Winter 2019/2020 den 2. Ringversuch (RV) zur quantitativen DNAm-Analyse mithilfe der Mini- und der Pyrosequenzierung durch. Dieser basierte auf den Erfahrungen des 1. RV 2018/2019, dessen Ergebnisse in dieser Ausgabe ebenfalls vorgestellt werden. Die aktuelle Studie umfasst Analyseergebnisse aus 12 Laboren (ingesamt 14 teilnehmende Labore), von denen einige beide Methoden angewandt haben. Zusätzlich führten 4 Labore eine Altersschätzung an den RV-Proben mit eigenen Markerkombinationen und Modellen durch. Da diese auf unterschiedlichen Referenzdaten und Markerkombinationen beruhen, erfolgte kein qualitativer Vergleich der Modelle, sondern das grundsätzliche Potenzial der Methodik wurde verdeutlicht. Ziele des RV waren die Evaluierung der Vergleichbarkeit der DNAm-Messungen und die Bewertung möglicher Einflussfaktoren, wie Extraktionsmethode und verwendetes Gerät.
Die Ergebnisse zeigen, dass sich die gemessenen DNAm-Werte der untersuchten Marker sowohl zwischen Mini- und Pyrosequenzierung als auch innerhalb der jeweiligen Methode zwischen den Laboren unterscheiden können, sodass mit Schwankungen gerechnet werden muss.
Die quantitative Analyse der relativen DNA-Methylierung gilt als eine der vielversprechendsten Methoden der molekularen Altersschätzung. Viele Studien der letzten Jahre identifizierten geeignete Positionen im Genom, deren DNA-Methylierung sich altersabhängig verändert. Für den Einsatz dieser Methode in der Routine- bzw. Fallarbeit ist es von großer Bedeutung, angewandte Analysetechniken zu validieren. Als ein Teilaspekt dieser Validierung sollte die Vergleichbarkeit der Analyseergebnisse zur DNA-Methylierung mithilfe der Mini- und Pyrosequenzierung zwischen verschiedenen Laboren evaluiert werden. Die Arbeitsgruppe „Molekulare Altersschätzung“ der Deutschen Gesellschaft für Rechtsmedizin (DGRM) führte hierzu den ersten, technischen Ringversuch durch, der 4 Positionen in den Genen PDE4C, EDARADD, SST und KLF14 umfasste. Diese Marker waren in vorangegangenen Studien als altersabhängige Biomarker charakterisiert worden. Am Ringversuch nahmen 12 Labore teil, wobei jedes die Wahl zwischen der Minisequenzierung und/oder der Pyrosequenzierung für die quantitative Methylierungsanalyse hatte. Jedem teilnehmenden Labor wurden Blut- und Speichelproben von 3 Personen unterschiedlichen Alters übersandt. Die Wahl der Reagenzien für die Probenbearbeitung wurde den Teilnehmern freigestellt.
Die Ergebnisse der Minisequenzierung zeigten systematische Abweichungen zwischen den Laboren, die am ehesten auf die Verwendung unterschiedlicher Reagenzien und Analyseplattformen zurückzuführen sein können. Die Resultate der Pyrosequenzierung hingegen wiesen nicht auf systematische Abweichungen zwischen den Laboren hin, hier zeigte sich jedoch die Tendenz einer markerabhängigen Abweichung. Darüber hinaus konnten Unterschiede hinsichtlich technischer Probleme zwischen Laboren mit mehr Erfahrung in der jeweiligen Sequenzierungsmethode und Laboren mit weniger Erfahrung festgestellt werden. Sowohl die Beobachtung von systematischen als auch die von markerabhängigen Abweichungen lässt den Schluss zu, dass eine Übertragung von Analysemethoden zwischen Laboren grundsätzlich möglich ist, eine Anpassung des jeweiligen Modells zur Altersschätzung jedoch notwendig sein kann.
Purpose
Over the course of COVID-19 pandemic, evidence has accumulated that SARS-CoV-2 infections may affect multiple organs and have serious clinical sequelae, but on-site clinical examinations with non-hospitalized samples are rare. We, therefore, aimed to systematically assess the long-term health status of samples of hospitalized and non-hospitalized SARS-CoV-2 infected individuals from three regions in Germany.
Methods
The present paper describes the COVIDOM-study within the population-based cohort platform (POP) which has been established under the auspices of the NAPKON infrastructure (German National Pandemic Cohort Network) of the national Network University Medicine (NUM). Comprehensive health assessments among SARS-CoV-2 infected individuals are conducted at least 6 months after the acute infection at the study sites Kiel, Würzburg and Berlin. Potential participants were identified and contacted via the local public health authorities, irrespective of the severity of the initial infection. A harmonized examination protocol has been implemented, consisting of detailed assessments of medical history, physical examinations, and the collection of multiple biosamples (e.g., serum, plasma, saliva, urine) for future analyses. In addition, patient-reported perception of the impact of local pandemic-related measures and infection on quality-of-life are obtained.
Results
As of July 2021, in total 6813 individuals infected in 2020 have been invited into the COVIDOM-study. Of these, about 36% wished to participate and 1295 have already been examined at least once.
Conclusion
NAPKON-POP COVIDOM-study complements other Long COVID studies assessing the long-term consequences of an infection with SARS-CoV-2 by providing detailed health data of population-based samples, including individuals with various degrees of disease severity.
Trial registration
Registered at the German registry for clinical studies (DRKS00023742).
Background
Increasing incidence of invasive infections caused by rare fungi was observed over the recent years.
Case
Here, we describe the first reported case of an infection caused by the thermophilic mold Talaromyces thermophilus. Cultivation and, hence, identification of this fastidious organism is challenging since standard incubation conditions are not sufficient. Retrospective analysis of patient samples and in vitro experiments demonstrated that testing for fungal antigens, i.e., the cell wall components galactomannan and β-1,3-D-glucan, is a promising tool.
Purpose
The ongoing pandemic caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2) has stressed health systems worldwide. Patients with chronic kidney disease (CKD) seem to be more prone to a severe course of coronavirus disease (COVID-19) due to comorbidities and an altered immune system. The study’s aim was to identify factors predicting mortality among SARS-CoV-2-infected patients with CKD.
Methods
We analyzed 2817 SARS-CoV-2-infected patients enrolled in the Lean European Open Survey on SARS-CoV-2-infected patients and identified 426 patients with pre-existing CKD. Group comparisons were performed via Chi-squared test. Using univariate and multivariable logistic regression, predictive factors for mortality were identified.
Results
Comparative analyses to patients without CKD revealed a higher mortality (140/426, 32.9% versus 354/2391, 14.8%). Higher age could be confirmed as a demographic predictor for mortality in CKD patients (> 85 years compared to 15–65 years, adjusted odds ratio (aOR) 6.49, 95% CI 1.27–33.20, p = 0.025). We further identified markedly elevated lactate dehydrogenase (> 2 × upper limit of normal, aOR 23.21, 95% CI 3.66–147.11, p < 0.001), thrombocytopenia (< 120,000/µl, aOR 11.66, 95% CI 2.49–54.70, p = 0.002), anemia (Hb < 10 g/dl, aOR 3.21, 95% CI 1.17–8.82, p = 0.024), and C-reactive protein (≥ 30 mg/l, aOR 3.44, 95% CI 1.13–10.45, p = 0.029) as predictors, while renal replacement therapy was not related to mortality (aOR 1.15, 95% CI 0.68–1.93, p = 0.611).
Conclusion
The identified predictors include routinely measured and universally available parameters. Their assessment might facilitate risk stratification in this highly vulnerable cohort as early as at initial medical evaluation for SARS-CoV-2.
Hintergrund und Ziel
Telemedizinische Schlaganfall-Netzwerke tragen dazu bei, die Schlaganfallversorgung und insbesondere den Zugang zu zeitkritischen Schlaganfalltherapien in vorrangig strukturschwachen, ländlichen Regionen zu gewährleisten. Ziel ist eine Darstellung der Nutzungsfrequenz und regionalen Verteilung dieser Versorgungsstruktur.
Methoden
Die Kommission „Telemedizinische Schlaganfallversorgung“ der Deutschen Schlaganfall-Gesellschaft führte eine Umfragestudie in allen Schlaganfall-Netzwerken durch.
Ergebnisse
In Deutschland sind 22 telemedizinische Schlaganfall-Netzwerke aktiv, welche insgesamt 43 Zentren (pro Netzwerk: Median 1,5, Interquartilsabstand [IQA] 1–3) sowie 225 Kooperationskliniken (pro Netzwerk: Median 9, IQA 4–17) umfassen und an einem unmittelbaren Zugang zur Schlaganfallversorgung für 48 Mio. Menschen teilhaben. Im Jahr 2018 wurden 38.211 Telekonsile (pro Netzwerk: Median 1340, IQA 319–2758) durchgeführt. Die Thrombolyserate betrug 14,1 % (95 %-Konfidenzintervall 13,6–14,7 %), eine Verlegung zur Thrombektomie wurde bei 7,9 % (95 %-Konfidenzintervall 7,5–8,4 %) der ischämischen Schlaganfallpatienten initiiert. Das Finanzierungssystem ist uneinheitlich mit einem Vergütungssystem für die Zentrumsleistungen in nur drei Bundesländern.
Diskussion
Etwa jeder 10. Schlaganfallpatient wird telemedizinisch behandelt. Die telemedizinischen Schlaganfall-Netzwerke erreichen vergleichbar hohe Lyseraten und Verlegungen zur Thrombektomie wie neurologische Stroke-Units und tragen zur Sicherstellung einer flächendeckenden Schlaganfallversorgung bei. Eine netzwerkübergreifende Sicherstellung der Finanzierung und einheitliche Erhebung von Qualitätssicherungsdaten haben das Potenzial diese Versorgungsstruktur zukünftig weiter zu stärken.
Purpose
Diaschisis of cerebrocerebellar loops contributes to cognitive and motor deficits in pediatric cerebellar brain tumor survivors. We used a cerebellar white matter atlas and hypothesized that lesion symptom mapping may reveal the critical lesions of cerebellar tracts.
Methods
We examined 31 long-term survivors of pediatric posterior fossa tumors (13 pilocytic astrocytoma, 18 medulloblastoma). Patients underwent neuronal imaging, examination for ataxia, fine motor and cognitive function, planning abilities, and executive function. Individual consolidated cerebellar lesions were drawn manually onto patients’ individual MRI and normalized into Montreal Neurologic Institute (MNI) space for further analysis with voxel-based lesion symptom mapping.
Results
Lesion symptom mapping linked deficits of motor function to the superior cerebellar peduncle (SCP), deep cerebellar nuclei (interposed nucleus (IN), fastigial nucleus (FN), ventromedial dentate nucleus (DN)), and inferior vermis (VIIIa, VIIIb, IX, X). Statistical maps of deficits of intelligence and executive function mapped with minor variations to the same cerebellar structures.
Conclusion
We identified lesions to the SCP next to deep cerebellar nuclei as critical for limiting both motor and cognitive function in pediatric cerebellar tumor survivors. Future strategies safeguarding motor and cognitive function will have to identify patients preoperatively at risk for damage to these critical structures and adapt multimodal therapeutic options accordingly.
Purpose
To investigate the association of patients’ sex with recurrence and disease progression in patients treated with intravesical bacillus Calmette–Guérin (BCG) for T1G3/HG urinary bladder cancer (UBC).
Materials and methods
We analyzed the data of 2635 patients treated with adjuvant intravesical BCG for T1 UBC between 1984 and 2019. We accounted for missing data using multiple imputations and adjusted for covariate imbalance between males and females using inverse probability weighting (IPW). Crude and IPW-adjusted Cox regression analyses were used to estimate the hazard ratios (HR) with their 95% confidence intervals (CI) for the association of patients’ sex with HG-recurrence and disease progression.
Results
A total of 2170 (82%) males and 465 (18%) females were available for analysis. Overall, 1090 (50%) males and 244 (52%) females experienced recurrence, and 391 (18%) males and 104 (22%) females experienced disease progression. On IPW-adjusted Cox regression analyses, female sex was associated with disease progression (HR 1.25, 95%CI 1.01–1.56, p = 0.04) but not with recurrence (HR 1.06, 95%CI 0.92–1.22, p = 0.41). A total of 1056 patients were treated with adequate BCG. In these patients, on IPW-adjusted Cox regression analyses, patients’ sex was not associated with recurrence (HR 0.99, 95%CI 0.80–1.24, p = 0.96), HG-recurrence (HR 1.00, 95%CI 0.78–1.29, p = 0.99) or disease progression (HR 1.12, 95%CI 0.78–1.60, p = 0.55).
Conclusion
Our analysis generates the hypothesis of a differential response to BCG between males and females if not adequately treated. Further studies should focus on sex-based differences in innate and adaptive immune system and their association with BCG response.
Purpose
While [\(^{18}\)F]-fluorodeoxyglucose ([\(^{18}\)F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such as neutrophils or macrophages. Recently, molecular imaging probes targeting fibroblast activation protein α (FAP), which is overexpressed in a variety of cancer-associated fibroblasts, have become available and might constitute a feasible alternative to FDG PET/CT.
Methods
Ten consecutive, treatment-naïve patients (8 males, 2 females; mean age, 62 ± 9 years) with biopsy-proven OSCC underwent both whole-body [\(^{18}\)F]FDG and [\(^{68}\)Ga]FAPI-04 (FAP-directed) PET/CT for primary staging prior to tumor resection and cervical lymph node dissection. Detection of the primary tumor, as well as the presence and number of lymph node and distant metastases was analysed. Intensity of tracer accumulation was assessed by means of maximum (SUV\(_{max}\)) and peak (SUV\(_{peak}\) standardized uptake values. Histological work-up including immunohistochemical staining for FAP served as standard of reference.
Results
[\(^{18}\)F]FDG and FAP-directed PET/CT detected all primary tumors with a SUVmax of 25.5 ± 13.2 (FDG) and 20.5 ± 6.4 (FAP-directed) and a SUVpeak of 16.1 ± 10.3 ([\(^{18}\)F]FDG) and 13.8 ± 3.9 (FAP-directed), respectively. Regarding cervical lymph node metastases, FAP-directed PET/CT demonstrated comparable sensitivity (81.3% vs. 87.5%; P = 0.32) and specificity (93.3% vs. 81.3%; P = 0.16) to [\(^{18}\)F]FDG PET/CT. FAP expression on the cell surface of cancer-associated fibroblasts in both primary lesions as well as lymph nodes metastases was confirmed in all samples.
Conclusion
FAP-directed PET/CT in OSCC seems feasible. Future research to investigate its potential to improve patient staging is highly warranted.
Purpose
FAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET/CT imaging, demonstrated in previous studies rapid and high tumor uptake. The purpose of this study is the head-to-head intra-individual comparison of \(^{68}\)Ga-FAPI versus standard-of-care \(^{18}\)F-FDG in PET/CT in organ biodistribution and tumor uptake in patients with various cancers.
Material and Methods
This international retrospective multicenter analysis included PET/CT data from 71 patients from 6 centers who underwent both \(^{68}\)Ga-FAPI and \(^{18}\)F-FDG PET/CT within a median time interval of 10 days (range 1–89 days). Volumes of interest (VOIs) were manually drawn in normal organs and tumor lesions to quantify tracer uptake by SUVmax and SUVmean. Furthermore, tumor-to-background ratios (TBR) were generated (SUVmax tumor/ SUVmax organ).
Results
A total of 71 patients were studied of, which 28 were female and 43 male (median age 60). In 41 of 71 patients, the primary tumor was present. Forty-three of 71 patients exhibited 162 metastatic lesions. \(^{68}\)Ga-FAPI uptake in primary tumors and metastases was comparable to 18F-FDG in most cases. The SUVmax was significantly lower for \(^{68}\)Ga-FAPI than \(^{18}\)F-FDG in background tissues such as the brain, oral mucosa, myocardium, blood pool, liver, pancreas, and colon. Thus, \(^{68}\)Ga-FAPI TBRs were significantly higher than 18F-FDG TBRs in some sites, including liver and bone metastases.
Conclusion
Quantitative tumor uptake is comparable between \(^{68}\)Ga-FAPI and \(^{18}\)F-FDG, but lower background uptake in most normal organs results in equal or higher TBRs for \(^{68}\)Ga-FAPI. Thus, \(^{68}\)Ga-FAPI PET/CT may yield improved diagnostic information in various cancers and especially in tumor locations with high physiological \(^{18}\)F-FDG uptake.
Purpose
To evaluate whether a deep learning model (DLM) could increase the detection sensitivity of radiologists for intracranial aneurysms on CT angiography (CTA) in aneurysmal subarachnoid hemorrhage (aSAH).
Methods
Three different DLMs were trained on CTA datasets of 68 aSAH patients with 79 aneurysms with their outputs being combined applying ensemble learning (DLM-Ens). The DLM-Ens was evaluated on an independent test set of 104 aSAH patients with 126 aneuryms (mean volume 129.2 ± 185.4 mm3, 13.0% at the posterior circulation), which were determined by two radiologists and one neurosurgeon in consensus using CTA and digital subtraction angiography scans. CTA scans of the test set were then presented to three blinded radiologists (reader 1: 13, reader 2: 4, and reader 3: 3 years of experience in diagnostic neuroradiology), who assessed them individually for aneurysms. Detection sensitivities for aneurysms of the readers with and without the assistance of the DLM were compared.
Results
In the test set, the detection sensitivity of the DLM-Ens (85.7%) was comparable to the radiologists (reader 1: 91.2%, reader 2: 86.5%, and reader 3: 86.5%; Fleiss κ of 0.502). DLM-assistance significantly increased the detection sensitivity (reader 1: 97.6%, reader 2: 97.6%,and reader 3: 96.0%; overall P=.024; Fleiss κ of 0.878), especially for secondary aneurysms (88.2% of the additional aneurysms provided by the DLM).
Conclusion
Deep learning significantly improved the detection sensitivity of radiologists for aneurysms in aSAH, especially for secondary aneurysms. It therefore represents a valuable adjunct for physicians to establish an accurate diagnosis in order to optimize patient treatment.
Purpose
Tiapride is commonly used in Europe for the treatment of tics. The aim of this study was to examine the relationship between dose and serum concentrations of tiapride and potential influential pharmacokinetic factors in children and adolescents. In addition, a preliminary therapeutic reference range for children and adolescents with tics treated with tiapride was calculated.
Methods
Children and adolescents treated with tiapride at three university hospitals and two departments of child and adolescents psychiatry in Germany and Austria were included in the study. Patient characteristics, doses, serum concentrations, and therapeutic outcome were assessed during clinical routine care using standardised measures.
Results
In the 49 paediatric patients (83.7% male, mean age = 12.5 years), a positive correlation was found between tiapride dose (median 6.9 mg/kg, range 0.97–19.35) and serum concentration with marked inter-individual variability. The variation in dose explained 57% of the inter-patient variability in tiapride serum concentrations; age, gender, and concomitant medication did not contribute to the variability. The symptoms improved in 83.3% of the patients. 27.1% of the patients had mild or moderate ADRs. No patient suffered from severe ADRs.
Conclusions
This study shows that tiapride treatment was effective and safe in most patients with tics. Compared with the therapeutic concentration range established for adults with Chorea Huntington, our data hinted at a lower lower limit (560 ng/ml) and similar upper limit (2000 ng/ml).
The EU chemicals strategy for sustainability (CSS) asserts that both human health and the environment are presently threatened and that further regulation is necessary. In a recent Guest Editorial, members of the German competent authority for risk assessment, the BfR, raised concerns about the scientific justification for this strategy. The complexity and interdependence of the networks of regulation of chemical substances have ensured that public health and wellbeing in the EU have continuously improved. A continuous process of improvement in consumer protection is clearly desirable but any initiative directed towards this objective must be based on scientific knowledge. It must not confound risk with other factors in determining policy. This conclusion is fully supported in the present Commentary including the request to improve both, data collection and the time-consuming and bureaucratic procedures that delay the publication of regulations.
Since the addition of fluoride to drinking water in the 1940s, there have been frequent and sometimes heated discussions regarding its benefits and risks. In a recently published review, we addressed the question if current exposure levels in Europe represent a risk to human health. This review was discussed in an editorial asking why we did not calculate benchmark doses (BMD) of fluoride neurotoxicity for humans. Here, we address the question, why it is problematic to calculate BMDs based on the currently available data. Briefly, the conclusions of the available studies are not homogeneous, reporting negative as well as positive results; moreover, the positive studies lack control of confounding factors such as the influence of well-known neurotoxicants. We also discuss the limitations of several further epidemiological studies that did not meet the inclusion criteria of our review. Finally, it is important to not only focus on epidemiological studies. Rather, risk analysis should consider all available data, including epidemiological, animal, as well as in vitro studies. Despite remaining uncertainties, the totality of evidence does not support the notion that fluoride should be considered a human developmental neurotoxicant at current exposure levels in European countries.
Objective
The current article encompasses a literature review and recommendations for radiotherapy in nodal oligorecurrent prostate cancer.
Materials and methods
A literature review focused on studies comparing metastasis-directed stereotactic ablative radiotherapy (SABR) vs. external elective nodal radiotherapy (ENRT) and studies analyzing recurrence patterns after local nodal treatment was performed. The DEGRO Prostate Cancer Expert Panel discussed the results and developed treatment recommendations.
Results
Metastasis-directed radiotherapy results in high local control (often > 90% within a follow-up of 1–2 years) and can be used to improve progression-free survival or defer androgen deprivation therapy (ADT) according to prospective randomized phase II data. Distant progression after involved-node SABR only occurs within a few months in the majority of patients. ENRT improves metastases-free survival rates with increased toxicity in comparison to SABR according to retrospective comparative studies. The majority of nodal recurrences after initial local treatment of pelvic nodal metastasis are detected within the true pelvis and common iliac vessels.
Conclusion
ENRT with or without a boost should be preferred to SABR in pelvic nodal recurrences. In oligometastatic prostate cancer with distant (extrapelvic) nodal recurrences, SABR alone can be performed in selected cases. Application of additional systemic treatments should be based on current guidelines, with ADT as first-line treatment for hormone-sensitive prostate cancer. Only in carefully selected patients can radiotherapy be initially used without additional ADT outside of the current standard recommendations. Results of (randomized) prospective studies are needed for definitive recommendations.
Purpose
To fully automatically derive quantitative parameters from late gadolinium enhancement (LGE) cardiac MR (CMR) in patients with myocardial infarction and to investigate if phase sensitive or magnitude reconstructions or a combination of both results in best segmentation accuracy.
Methods
In this retrospective single center study, a convolutional neural network with a U-Net architecture with a self-configuring framework (“nnU-net”) was trained for segmentation of left ventricular myocardium and infarct zone in LGE-CMR. A database of 170 examinations from 78 patients with history of myocardial infarction was assembled. Separate fitting of the model was performed, using phase sensitive inversion recovery, the magnitude reconstruction or both contrasts as input channels.
Manual labelling served as ground truth. In a subset of 10 patients, the performance of the trained models was evaluated and quantitatively compared by determination of the Sørensen-Dice similarity coefficient (DSC) and volumes of the infarct zone compared with the manual ground truth using Pearson’s r correlation and Bland-Altman analysis.
Results
The model achieved high similarity coefficients for myocardium and scar tissue. No significant difference was observed between using PSIR, magnitude reconstruction or both contrasts as input (PSIR and MAG; mean DSC: 0.83 ± 0.03 for myocardium and 0.72 ± 0.08 for scars). A strong correlation for volumes of infarct zone was observed between manual and model-based approach (r = 0.96), with a significant underestimation of the volumes obtained from the neural network.
Conclusion
The self-configuring nnU-net achieves predictions with strong agreement compared to manual segmentation, proving the potential as a promising tool to provide fully automatic quantitative evaluation of LGE-CMR.
In hemostasis and thrombosis, the complex process of thrombus formation involves different molecular pathways of platelet and coagulation activation. These pathways are considered as operating together at the same time, but this has not been investigated. The objective of our study was to elucidate the time-dependency of key pathways of thrombus and clot formation, initiated by collagen and tissue factor surfaces, where coagulation is triggered via the extrinsic route. Therefore, we adapted a microfluidics whole-blood assay with the Maastricht flow chamber to acutely block molecular pathways by pharmacological intervention at desired time points. Application of the technique revealed crucial roles of glycoprotein VI (GPVI)-induced platelet signaling via Syk kinase as well as factor VIIa-induced thrombin generation, which were confined to the first minutes of thrombus buildup. A novel anti-GPVI Fab EMF-1 was used for this purpose. In addition, platelet activation with the protease-activating receptors 1/4 (PAR1/4) and integrin αIIbβ3 appeared to be prolongedly active and extended to later stages of thrombus and clot formation. This work thereby revealed a more persistent contribution of thrombin receptor-induced platelet activation than of collagen receptor-induced platelet activation to the thrombotic process.
Prerequisite to any biological laboratory assay employing living animals is consideration about its necessity, feasibility, ethics and the potential harm caused during an experiment. The imperative of these thoughts has led to the formulation of the 3R-principle, which today is a pivotal scientific standard of animal experimentation worldwide. The rising amount of laboratory investigations utilizing living animals throughout the last decades, either for regulatory concerns or for basic science, demands the development of alternative methods in accordance with 3R to help reduce experiments in mammals. This demand has resulted in investigation of additional vertebrate species displaying favourable biological properties. One prominent species among these is the zebrafish (Danio rerio), as these small laboratory ray-finned fish are well established in science today and feature outstanding biological characteristics. In this review, we highlight the advantages and general prerequisites of zebrafish embryos and larvae before free-feeding stages for toxicological testing, with a particular focus on cardio-, neuro, hepato- and nephrotoxicity. Furthermore, we discuss toxicokinetics, current advances in utilizing zebrafish for organ toxicity testing and highlight how advanced laboratory methods (such as automation, advanced imaging and genetic techniques) can refine future toxicological studies in this species.
In bone tissue engineering, the design of 3D systems capable of recreating composition, architecture and micromechanical environment of the native extracellular matrix (ECM) is still a challenge. While perfusion bioreactors have been proposed as potential tool to apply biomechanical stimuli, its use has been limited to a low number of biomaterials. In this work, we propose the culture of human mesenchymal stem cells (hMSC) in biomimetic mineralized recombinant collagen scaffolds with a perfusion bioreactor to simultaneously provide biochemical and biophysical cues guiding stem cell fate. The scaffolds were fabricated by mineralization of recombinant collagen in the presence of magnesium (RCP.MgAp). The organic matrix was homogeneously mineralized with apatite nanocrystals, similar in composition to those found in bone. X-Ray microtomography images revealed isotropic porous structure with optimum porosity for cell ingrowth. In fact, an optimal cell repopulation through the entire scaffolds was obtained after 1 day of dynamic seeding in the bioreactor. Remarkably, RCP.MgAp scaffolds exhibited higher cell viability and a clear trend of up-regulation of osteogenic genes than control (non-mineralized) scaffolds. Results demonstrate the potential of the combination of biomimetic mineralization of recombinant collagen in presence of magnesium and dynamic culture of hMSC as a promising strategy to closely mimic bone ECM.
Immunosenescence is considered a possible factor in the development of age-related macular degeneration and choroidal neovascularization (CNV). However, age-related changes of myeloid cells (MCs), such as microglia and macrophages, in the healthy retina or during CNV formation are ill-defined. In this study, Cx3cr1-positive MCs were isolated by fluorescence-activated cell sorting from six-week (young) and two-year-old (old) Cx3cr1\(^{GFP/+}\) mice, both during physiological aging and laser-induced CNV development. High-throughput RNA-sequencing was performed to define the age-dependent transcriptional differences in MCs during physiological aging and CNV development, complemented by immunohistochemical characterization and the quantification of MCs, as well as CNV size measurements. These analyses revealed that myeloid cells change their transcriptional profile during both aging and CNV development. In the steady state, senescent MCs demonstrated an upregulation of factors contributing to cell proliferation and chemotaxis, such as Cxcl13 and Cxcl14, as well as the downregulation of microglial signature genes. During CNV formation, aged myeloid cells revealed a significant upregulation of angiogenic factors such as Arg1 and Lrg1 concomitant with significantly enlarged CNV and an increased accumulation of MCs in aged mice in comparison to young mice. Future studies need to clarify whether this observation is an epiphenomenon or a causal relationship to determine the role of immunosenescence in CNV formation.
Introduction: Familial dilated cardiomyopathy (DCM) is clinically variable and has been associated with mutations in more than 50 genes. Rapid improvements in DNA sequencing have led to the identification of diverse rare variants with unknown significance (VUS), which underlines the importance of functional analyses. In this study, by investigating human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs), we evaluated the pathogenicity of the p.C335R sodium voltage-gated channel alpha subunit 5 (SCN5a) variant in a large family with familial DCM and conduction disease. Methods: A four-generation family with autosomal dominant familial DCM was investigated. Next-generation sequencing (NGS) was performed in all 16 family members. Clinical deep phenotyping, including endomyocardial biopsy, was performed. Skin biopsies from two patients and one healthy family member were used to generate human-induced pluripotent stem cells (iPSCs), which were then differentiated into cardiomyocytes. Patch-clamp analysis with Xenopus oocytes and iPSC-CMs were performed. Results: A SCN5a variant (c.1003T>C; p.C335R) could be detected in all family members with DCM or conduction disease. A novel truncating TTN variant (p.Ser24998LysfsTer28) could also be identified in two family members with DCM. Family members with the SCN5a variant (p.C335R) showed significantly longer PQ and QRS intervals and lower left ventricular ejection fractions (LV-EF). All four patients who received CRT-D were non-responders. Electrophysiological analysis with Xenopus oocytes showed a loss of function in SCN5a p.C335R. Na\(^+\) channel currents were also reduced in iPSC-CMs from DCM patients. Furthermore, iPSC-CM with compound heterozygosity (SCN5a p.C335R and TTNtv) showed significant dysregulation of sarcomere structures, which may be contributed to the severity of the disease and earlier onset of DCM. Conclusion: The SCN5a p.C335R variant is causing a loss of function of peak INa in patients with DCM and cardiac conduction disease. The co-existence of genetic variants in channels and structural genes (e.g., SCN5a p.C335R and TTNtv) increases the severity of the DCM phenotype.
A viral infection involves entry and replication of viral nucleic acid in a host organism, subsequently leading to biochemical and structural alterations in the host cell. In the case of SARS-CoV-2 viral infection, over-activation of the host immune system may lead to lung damage. Albeit the regeneration and fibrotic repair processes being the two protective host responses, prolonged injury may lead to excessive fibrosis, a pathological state that can result in lung collapse. In this review, we discuss regeneration and fibrosis processes in response to SARS-CoV-2 and provide our viewpoint on the triggering of alveolar regeneration in coronavirus disease 2019 (COVID-19) patients.
Advances in breast cancer management and extracellular vesicle research, a bibliometric analysis
(2021)
Extracellular vesicles transport variable content and have crucial functions in cell–cell communication. The role of extracellular vesicles in cancer is a current hot topic, and no bibliometric study has ever analyzed research production regarding their role in breast cancer and indicated the trends in the field. In this way, we aimed to investigate the trends in breast cancer management involved with extracellular vesicle research. Articles were retrieved from Scopus, including all the documents published concerning breast cancer and extracellular vesicles. We analyzed authors, journals, citations, affiliations, and keywords, besides other bibliometric analyses, using R Studio version 3.6.2. and VOSviewer version 1.6.0. A total of 1151 articles were retrieved, and as the main result, our analysis revealed trending topics on biomarkers of liquid biopsy, drug delivery, chemotherapy, autophagy, and microRNA. Additionally, research related to extracellular vesicles in breast cancer has been focused on diagnosis, treatment, and mechanisms of action of breast tumor-derived vesicles. Future studies are expected to explore the role of extracellular vesicles on autophagy and microRNA, besides investigating the application of extracellular vesicles from liquid biopsies for biomarkers and drug delivery, enabling the development and validation of therapeutic strategies for specific cancers.
Previous research on the melt electrowriting (MEW) of poly(vinylidene difluoride) (PVDF) resulted in electroactive fibers, however, printing more than five layers is challenging. Here, we investigate the influence of a heated collector to adjust the solidification rate of the PVDF jet so that it adheres sufficiently to each layer. A collector temperature of 110°C is required to improve fiber processing, resulting in a total of 20 fiber layers. For higher temperatures and higher layers, an interesting phenomenon occurred, where the intersection points of the fibers coalesced into periodic spheres of diameter 206 ± 52 μm (26G, 150°C collector temperature, 2000 mm/min, 10 layers in x- and y-direction).The heated collector is an important component of a MEW printer that allows polymers with a high melting point to be processable with increased layers.
Lithium salts are the first-line prophylaxis treatment for bipolar disorder in most guidelines. The majority of bipolar women are treated with mood stabilizers at the time they wish to get pregnant. One reason for this is the rising average age at first childbirth, at least in the high-income countries, which increases in general the likelihood of a medication with psychotropic drugs. Previously, lithium exposition during pregnancy was thought to strongly increase the risk of severe cardiac malformation. However, recent studies only point to a low teratogenic risk, so nowadays an increasing number of women are getting pregnant with ongoing lithium treatment. Regarding lithium medication during breastfeeding, there is evidence that lithium transfers to the breastmilk and can also be detected in the infants' serum. The influence on the infant is still a largely understudied topic. Regular monitoring of the infants' renal clearance, thyroid function, and lithium levels is warranted when breastfeeding under lithium exposure. In this case series, we present three case reports of bipolar mothers who were treated with lithium during pregnancy and breastfeeding to add to the scarce literature on this important topic. In short, we strengthen the importance of therapeutic drug monitoring due to fluctuating plasma levels during pregnancy and after birth, and we can report the birth and development of three healthy infants despite lithium medication during pregnancy and breastfeeding.
Inflammatory mechanisms in the pathophysiology of diabetic peripheral neuropathy (DN) — new aspects
(2021)
The pathogenesis of diabetic neuropathy is complex, and various pathogenic pathways have been proposed. A better understanding of the pathophysiology is warranted for developing novel therapeutic strategies. Here, we summarize recent evidence from experiments using animal models of type 1 and type 2 diabetes showing that low-grade intraneural inflammation is a facet of diabetic neuropathy. Our experimental data suggest that these mild inflammatory processes are a likely common terminal pathway in diabetic neuropathy associated with the degeneration of intraepidermal nerve fibers. In contrast to earlier reports claiming toxic effects of high-iron content, we found the opposite, i.e., nutritional iron deficiency caused low-grade inflammation and fiber degeneration while in normal or high non-heme iron nutrition no or only extremely mild inflammatory signs were identified in nerve tissue. Obesity and dyslipidemia also appear to trigger mild inflammation of peripheral nerves, associated with neuropathy even in the absence of overt diabetes mellitus. Our finding may be the experimental analog of recent observations identifying systemic proinflammatory activity in human sensorimotor diabetic neuropathy. In a rat model of type 1 diabetes, a mild neuropathy with inflammatory components could be induced by insulin treatment causing an abrupt reduction in HbA1c. This is in line with observations in patients with severe diabetes developing a small fiber neuropathy upon treatment-induced rapid HbA1c reduction. If the inflammatory pathogenesis could be further substantiated by data from human tissues and intervention studies, anti-inflammatory compounds with different modes of action may become candidates for the treatment or prevention of diabetic neuropathy.
Aside from the established immune-mediated etiology of multiple sclerosis (MS), compelling evidence implicates platelets as important players in disease pathogenesis. Specifically, numerous studies have highlighted that activated platelets promote the central nervous system (CNS)-directed adaptive immune response early in the disease course. Platelets, therefore, present a novel opportunity for modulating the neuroinflammatory process that characterizes MS. We hypothesized that the well-known antiplatelet agent acetylsalicylic acid (ASA) could inhibit neuroinflammation by affecting platelets if applied at low-dose and investigated its effect during experimental autoimmune encephalomyelitis (EAE) as a model to study MS. We found that oral administration of low-dose ASA alleviates symptoms of EAE accompanied by reduced inflammatory infiltrates and less extensive demyelination. Remarkably, the percentage of CNS-infiltrated CD4\(^+\) T cells, the major drivers of neuroinflammation, was decreased to 40.98 ± 3.28% in ASA-treated mice compared to 56.11 ± 1.46% in control animals at the disease maximum as revealed by flow cytometry. More interestingly, plasma levels of thromboxane A\(_2\) were decreased, while concentrations of platelet factor 4 and glycoprotein VI were not affected by low-dose ASA treatment. Overall, we demonstrate that low-dose ASA could ameliorate the platelet-dependent neuroinflammatory response in vivo, thus indicating a potential treatment approach for MS.
Patients with atrial fibrillation and previous ischemic stroke (IS) are at increased risk of cerebrovascular events despite anticoagulation. In these patients, treatment with non-vitamin K oral anticoagulants (NOAC) such as edoxaban reduced the probability and severity of further IS without increasing the risk of major bleeding. However, the detailed protective mechanism of edoxaban has not yet been investigated in a model of ischemia/reperfusion injury. Therefore, in the current study we aimed to assess in a clinically relevant setting whether treatment with edoxaban attenuates stroke severity, and whether edoxaban has an impact on the local cerebral inflammatory response and blood–brain barrier (BBB) function after experimental IS in mice. Focal cerebral ischemia was induced by transient middle cerebral artery occlusion in male mice receiving edoxaban, phenprocoumon or vehicle. Infarct volumes, functional outcome and the occurrence of intracerebral hemorrhage were assessed. BBB damage and the extent of local inflammatory response were determined. Treatment with edoxaban significantly reduced infarct volumes and improved neurological outcome and BBB function on day 1 and attenuated brain tissue inflammation. In summary, our study provides evidence that edoxaban might exert its protective effect in human IS by modulating different key steps of IS pathophysiology, but further studies are warranted.
LMNA-related dilated cardiomyopathy is an inherited heart disease caused by mutations in the LMNA gene encoding for lamin A/C. The disease is characterized by left ventricular enlargement and impaired systolic function associated with conduction defects and ventricular arrhythmias. We hypothesized that LMNA-mutated patients' induced Pluripotent Stem Cell-derived cardiomyocytes (iPSC-CMs) display electrophysiological abnormalities, thus constituting a suitable tool for deciphering the arrhythmogenic mechanisms of the disease, and possibly for developing novel therapeutic modalities. iPSC-CMs were generated from two related patients (father and son) carrying the same E342K mutation in the LMNA gene. Compared to control iPSC-CMs, LMNA-mutated iPSC-CMs exhibited the following electrophysiological abnormalities: (1) decreased spontaneous action potential beat rate and decreased pacemaker current (I\(_f\)) density; (2) prolonged action potential duration and increased L-type Ca\(^{2+}\) current (I\(_{Ca,L}\)) density; (3) delayed afterdepolarizations (DADs), arrhythmias and increased beat rate variability; (4) DADs, arrhythmias and cessation of spontaneous firing in response to β-adrenergic stimulation and rapid pacing. Additionally, compared to healthy control, LMNA-mutated iPSC-CMs displayed nuclear morphological irregularities and gene expression alterations. Notably, KB-R7943, a selective inhibitor of the reverse-mode of the Na\(^+\)/Ca\(^{2+}\) exchanger, blocked the DADs in LMNA-mutated iPSC-CMs. Our findings demonstrate cellular electrophysiological mechanisms underlying the arrhythmias in LMNA-related dilated cardiomyopathy.
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). MS commonly affects the cerebellum causing acute and chronic symptoms. Cerebellar signs significantly contribute to clinical disability, and symptoms such as tremor, ataxia, and dysarthria are difficult to treat. Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies such as MS. In autopsy tissue from patients with MS, increased expression of FGF1, FGF2, FGF9, and FGFR1 was found in lesion areas. Recent research using mouse models has focused on regions such as the spinal cord, and data on the expression of FGF/FGFR in the cerebellum are not available. In recent EAE studies, we detected that oligodendrocyte-specific deletion of FGFRs results in a milder disease course, less cellular infiltrates, and reduced neurodegeneration in the spinal cord. The objective of this study was to characterize the role of FGFR1 in oligodendrocytes in the cerebellum. Conditional deletion of FGFR1 in oligodendrocytes (Fgfr1\(^{ind−/−}\) was achieved by tamoxifen application, EAE was induced using the MOG\(_{35-55}\) peptide. The cerebellum was analyzed by histology, immunohistochemistry, and western blot. At day 62 p.i., Fgfr1\(^{ind−/−}\) mice showed less myelin and axonal degeneration compared to FGFR1-competent mice. Infiltration of CD3(+) T cells, Mac3(+) cells, B220(+) B cells and IgG(+) plasma cells in cerebellar white matter lesions (WML) was less in Fgfr1\(^{ind−/−}\)mice. There were no effects on the number of OPC or mature oligodendrocytes in white matter lesion (WML). Expression of FGF2 and FGF9 associated with less myelin and axonal degeneration, and of the pro-inflammatory cytokines IL-1β, IL-6, and CD200 was downregulated in Fgfr1\(^{ind−/−}\) mice. The FGF/FGFR signaling protein pAkt, BDNF, and TrkB were increased in Fgfr1\(^{ind−/−}\) mice. These data suggest that cell-specific deletion of FGFR1 in oligodendrocytes has anti-inflammatory and neuroprotective effects in the cerebellum in the EAE disease model of MS.
It remains unclear if principal components of the local cerebral stroke immune response can be reliably and reproducibly observed in patients with acute large-vessel-occlusion (LVO) stroke. We prospectively studied a large independent cohort of n = 318 consecutive LVO stroke patients undergoing mechanical thrombectomy during which cerebral blood samples from within the occluded anterior circulation and systemic control samples from the ipsilateral cervical internal carotid artery were obtained. An extensive protocol was applied to homogenize the patient cohort and to standardize the procedural steps of endovascular sample collection, sample processing, and laboratory analyses. N = 58 patients met all inclusion criteria. (1) Mean total leukocyte counts were significantly higher within the occluded ischemic cerebral vasculature (I) vs. intraindividual systemic controls (S): +9.6%, I: 8114/µL ± 529 vs. S: 7406/µL ± 468, p = 0.0125. (2) This increase was driven by neutrophils: +12.1%, I: 7197/µL ± 510 vs. S: 6420/µL ± 438, p = 0.0022. Leukocyte influx was associated with (3) reduced retrograde collateral flow (R\(^2\) = 0.09696, p = 0.0373) and (4) greater infarct extent (R\(^2\) = 0.08382, p = 0.032). Despite LVO, leukocytes invade the occluded territory via retrograde collateral pathways early during ischemia, likely compromising cerebral hemodynamics and tissue integrity. This inflammatory response can be reliably observed in human stroke by harvesting immune cells from the occluded cerebral vascular compartment.
Background: Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), but prolonged cytopenia has also been reported. The underlying mechanism for prolonged cytopenia is poorly understood so far. Cases: Severe pancytopenia with grade 2-3 anemia was marked 2–3 months after treatment. Laboratory evaluation revealed undetectable levels of haptoglobin with increased reticulocyte counts. Coomb's tests were negative, no schistocytes were detected on blood smear, and infectious causes were ruled out. Increased erythropoiesis without lymphoma infiltration was noted on bone marrow biopsy. A spontaneous increase in haptoglobin and hemoglobin levels was observed after several weeks. For one patient, peripheral CAR-T levels were monitored over time. We observed a decline at the same time as hemoglobin levels began to rise, implying a potential causality. Conclusion: To our knowledge, we describe the first two cases of Coombs-negative hemolytic anemia after CAR-T treatment for B-cell lymphoma. We encourage routine monitoring for hemolytic anemia after CAR-T treatment and also encourage further investigations on the underlying mechanism.
Based on recent findings that show that depletion of factor XII (FXII) leads to better posttraumatic neurological recovery, we studied the effect of FXII-deficiency on post-traumatic cognitive and behavioral outcomes in female and male mice. In agreement with our previous findings, neurological deficits on day 7 after weight-drop traumatic brain injury (TBI) were significantly reduced in FXII\(^{−/−}\) mice compared to wild type (WT) mice. Also, glycoprotein Ib (GPIb)-positive platelet aggregates were more frequent in brain microvasculature of WT than FXII\(^{−/−}\) mice 3 months after TBI. Six weeks after TBI, memory for novel object was significantly reduced in both female and male WT but not in FXII\(^{−/−}\) mice compared to sham-operated mice. In the setting of automated home-cage monitoring of socially housed mice in IntelliCages, female WT mice but not FXII\(^{−/−}\) mice showed decreased exploration and reacted negatively to reward extinction one month after TBI. Since neuroendocrine stress after TBI might contribute to trauma-induced cognitive dysfunction and negative emotional contrast reactions, we measured peripheral corticosterone levels and the ration of heart, lung, and spleen weight to bodyweight. Three months after TBI, plasma corticosterone levels were significantly suppressed in both female and male WT but not in FXII\(^{−/−}\) mice, while the relative heart weight increased in males but not in females of both phenotypes when compared to sham-operated mice. Our results indicate that FXII deficiency is associated with efficient post-traumatic behavioral and neuroendocrine recovery.
Background: Phosphodiesterases (PDE) critically regulate myocardial cAMP and cGMP levels. PDE2 is stimulated by cGMP to hydrolyze cAMP, mediating a negative crosstalk between both pathways. PDE2 upregulation in heart failure contributes to desensitization to β-adrenergic overstimulation. After isoprenaline (ISO) injections, PDE2 overexpressing mice (PDE2 OE) were protected against ventricular arrhythmia. Here, we investigate the mechanisms underlying the effects of PDE2 OE on susceptibility to arrhythmias. Methods: Cellular arrhythmia, ion currents, and Ca\(^{2+}\)-sparks were assessed in ventricular cardiomyocytes from PDE2 OE and WT littermates. Results: Under basal conditions, action potential (AP) morphology were similar in PDE2 OE and WT. ISO stimulation significantly increased the incidence of afterdepolarizations and spontaneous APs in WT, which was markedly reduced in PDE2 OE. The ISO-induced increase in I\(_{CaL}\) seen in WT was prevented in PDE2 OE. Moreover, the ISO-induced, Epac- and CaMKII-dependent increase in I\(_{NaL}\) and Ca\(^{2+}\)-spark frequency was blunted in PDE2 OE, while the effect of direct Epac activation was similar in both groups. Finally, PDE2 inhibition facilitated arrhythmic events in ex vivo perfused WT hearts after reperfusion injury. Conclusion: Higher PDE2 abundance protects against ISO-induced cardiac arrhythmia by preventing the Epac- and CaMKII-mediated increases of cellular triggers. Thus, activating myocardial PDE2 may represent a novel intracellular anti-arrhythmic therapeutic strategy in HF.
Pharmacologic cardiac conditioning increases the intrinsic resistance against ischemia and reperfusion (I/R) injury. The cardiac conditioning response is mediated via complex signaling networks. These networks have been an intriguing research field for decades, largely advancing our knowledge on cardiac signaling beyond the conditioning response. The centerpieces of this system are the mitochondria, a dynamic organelle, almost acting as a cell within the cell. Mitochondria comprise a plethora of functions at the crossroads of cell death or survival. These include the maintenance of aerobic ATP production and redox signaling, closely entwined with mitochondrial calcium handling and mitochondrial permeability transition. Moreover, mitochondria host pathways of programmed cell death impact the inflammatory response and contain their own mechanisms of fusion and fission (division). These act as quality control mechanisms in cellular ageing, release of pro-apoptotic factors and mitophagy. Furthermore, recently identified mechanisms of mitochondrial regeneration can increase the capacity for oxidative phosphorylation, decrease oxidative stress and might help to beneficially impact myocardial remodeling, as well as invigorate the heart against subsequent ischemic insults. The current review highlights different pathways and unresolved questions surrounding mitochondria in myocardial I/R injury and pharmacological cardiac conditioning.